Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

122227 1378 31 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
3825 1378 31 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
644 1378 31 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
CHEMBL264100 1378 31 None -97 3 Rat 7.1 pEC50 = 7.1 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL None None None None 10.1016/S0960-894X(97)10042-7
44323260 107015 0 None - 1 Rat 6.0 pEC50 = 6.0 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL 845 32 10 10 0.7 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O 10.1016/S0960-894X(97)10042-7
CHEMBL315388 107015 0 None - 1 Rat 6.0 pEC50 = 6.0 Functional
Compound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscleCompound was evaluated for agonist activity against B1 receptor in rat ileum longitudinal smooth muscle
ChEMBL 845 32 10 10 0.7 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O 10.1016/S0960-894X(97)10042-7
11757682 122040 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assayAntagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 122040 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assayAntagonist activity against human Bradykinin receptor B1 was determined in a fluorescence imaging plate reader assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11214480 149179 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 514 7 4 5 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccc(CCC3=NCCN3)cc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL394370 149179 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 514 7 4 5 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccc(CCC3=NCCN3)cc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
57397292 70059 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939758 70059 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
54772237 65783 0 None 6 2 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834752 65783 0 None 6 2 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
60142570 125915 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
CHEMBL3648475 125915 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
60142706 125920 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648480 125920 0 None - 1 Human 10.0 pIC50 = 10 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
11570120 70056 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939755 70056 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
24970287 188423 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL502140 188423 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
46230121 202144 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 9 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL609157 202144 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 9 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
46230161 201420 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 561 7 2 10 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL604735 201420 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 561 7 2 10 3.3 CCN(NC(=O)c1cc(OC)no1)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
54582655 62196 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777969 62196 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587189 172441 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
CHEMBL447870 172441 0 None - 1 Human 9.9 pIC50 = 9.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
56594769 65726 0 None 6 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834619 65726 0 None 6 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
665 973 3 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
9916412 973 3 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
CHEMBL189123 973 3 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
665 973 3 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 973 3 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 973 3 None 1 4 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
46216675 200609 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 513 5 2 7 4.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCC(F)(F)CC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL599285 200609 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 513 5 2 7 4.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCC(F)(F)CC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
46230160 200581 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 10 2.7 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599153 200581 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 10 2.7 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
11387387 62194 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777967 62194 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
57523216 125916 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648476 125916 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
60142962 125928 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
CHEMBL3648488 125928 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
60142963 125929 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125929 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60143095 125930 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648490 125930 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
60141038 125934 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648494 125934 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
60141185 125942 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648502 125942 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
60141464 125948 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
CHEMBL3648508 125948 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
60141466 125950 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
CHEMBL3648510 125950 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
57398978 70058 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939757 70058 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
53248885 62185 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777958 62185 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
53248885 62185 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777958 62185 0 None 18 2 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57396447 70104 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 5 2 5 2.2 CN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939944 70104 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 5 2 5 2.2 CN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
57400696 70060 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939759 70060 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57392941 70099 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 6 2 5 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939939 70099 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 488 6 2 5 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
11442712 85226 0 None 9 2 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 85226 0 None 9 2 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
46230120 199209 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 9 3.9 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL589820 199209 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 547 7 2 9 3.9 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
46230203 200649 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 7 3.6 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599574 200649 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 7 3.6 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
57395448 70057 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939756 70057 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57398238 70101 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939941 70101 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2011.11.112
57391173 70103 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.2 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939943 70103 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.2 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
46230404 200359 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 492 6 2 7 5.2 CC(=O)Nn1c(Cl)cnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL597747 200359 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 492 6 2 7 5.2 CC(=O)Nn1c(Cl)cnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
56589598 65782 0 None 7 2 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834751 65782 0 None 7 2 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
11214819 62177 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777885 62177 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142704 125918 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648478 125918 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
60143096 125931 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648491 125931 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
60141324 125945 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648505 125945 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
57401664 70102 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 3 5 1.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939942 70102 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 3 5 1.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
11342704 62183 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777956 62183 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54586519 62204 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777977 62204 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587188 193371 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
CHEMBL525092 193371 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
54583617 62195 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777968 62195 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57390218 70061 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939760 70061 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
16108961 923 0 None 2 3 Human 9.4 pIC50 = 9.4 Functional
Antagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 923 0 None 2 3 Human 9.4 pIC50 = 9.4 Functional
Antagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 923 0 None 2 3 Human 9.4 pIC50 = 9.4 Functional
Antagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at African green monkey bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
60142703 125917 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648477 125917 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60141041 125936 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
CHEMBL3648496 125936 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
60141182 125939 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648499 125939 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
71229238 125943 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648503 125943 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
60141323 125944 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648504 125944 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
57392940 70091 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 434 5 2 5 1.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939931 70091 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 434 5 2 5 1.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
46230119 199208 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 8 4.5 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL589819 199208 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 8 4.5 CCN(NC(=O)c1cc(OC)no1)C(=O)NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
54581635 62178 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777886 62178 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
53360054 70089 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939929 70089 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
16747694 87953 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234097 87953 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
46230163 200410 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 6 4.7 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL598124 200410 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 532 5 2 6 4.7 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
11364466 62173 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777881 62173 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11341479 62205 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777978 62205 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587186 172718 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL450541 172718 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
54587514 62175 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777883 62175 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
46230990 200640 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 473 7 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(CF)CF)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL599490 200640 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 473 7 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(CF)CF)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
60142303 125902 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648462 125902 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142304 125903 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648463 125903 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142437 125906 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648466 125906 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142440 125908 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648468 125908 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142834 125923 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
CHEMBL3648483 125923 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
60142836 125925 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
CHEMBL3648485 125925 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
60141465 125949 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648509 125949 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
57398235 70093 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 462 7 2 5 2.0 CCCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939933 70093 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 462 7 2 5 2.0 CCCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
11168954 62174 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777882 62174 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587187 188711 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL504531 188711 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587187 188711 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL504531 188711 0 None - 1 Human 9.3 pIC50 = 9.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
46216847 200440 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 559 8 2 11 5.4 COc1cc(C(=O)Nc2nsnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL598349 200440 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 559 8 2 11 5.4 COc1cc(C(=O)Nc2nsnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
54581667 62202 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777975 62202 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142028 125894 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648455 125894 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142438 125907 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648467 125907 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142835 125924 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648484 125924 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60142963 125929 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125929 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
54772237 65783 0 None -6 2 Rabbit 9.2 pIC50 = 9.2 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834752 65783 0 None -6 2 Rabbit 9.2 pIC50 = 9.2 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
57396446 70092 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 448 6 2 5 1.6 CCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939932 70092 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 448 6 2 5 1.6 CCN1CC[C@H](NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)C(C)(C)C1 10.1016/j.bmcl.2011.11.112
46230202 200262 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 7 4.1 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL597115 200262 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 7 4.1 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
54581634 62176 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777884 62176 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
10239095 83915 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
CHEMBL220657 83915 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
57398237 70100 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2011.11.112
CHEMBL1939940 70100 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 5 3 5 1.8 CC1(C)CNCC[C@@H]1NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2011.11.112
46230309 199477 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 591 8 2 10 6.0 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc3ccccc32)on1 10.1016/j.bmcl.2009.11.120
CHEMBL591676 199477 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 591 8 2 10 6.0 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc3ccccc32)on1 10.1016/j.bmcl.2009.11.120
57398236 70098 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 6 2 5 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939938 70098 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 474 6 2 5 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CCC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
11477390 85161 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
CHEMBL225218 85161 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
46230941 201262 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 463 5 2 7 3.7 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL603907 201262 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 463 5 2 7 3.7 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
54587552 62193 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777966 62193 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
16221282 85537 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL227713 85537 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587181 188677 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL503847 188677 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
16221282 85537 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85537 0 None 13 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
25105469 187061 6 None 2 2 Rat 9.1 pIC50 = 9.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
CHEMBL491198 187061 6 None 2 2 Rat 9.1 pIC50 = 9.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
60142567 125912 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648472 125912 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
11386138 84441 0 None 8 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84441 0 None 8 2 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44587183 173226 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL452331 173226 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
57403391 70094 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 476 7 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939934 70094 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 476 7 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
10217706 83225 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
CHEMBL218605 83225 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
11363856 84535 0 None 13 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84535 0 None 13 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
11215488 62181 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777954 62181 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
46230067 199488 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 541 5 2 4 4.8 CCN(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL591742 199488 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 541 5 2 4 4.8 CCN(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
46230939 200282 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 5 2 7 3.2 CC(C)N(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
CHEMBL597235 200282 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 5 2 7 3.2 CC(C)N(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
46216846 201229 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 543 8 2 11 4.9 COc1cc(C(=O)Nc2nonc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL603668 201229 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 543 8 2 11 4.9 COc1cc(C(=O)Nc2nonc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
56594642 65723 0 None 21 2 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834616 65723 0 None 21 2 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
44587182 188690 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL504119 188690 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
57394684 70096 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 510 7 2 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(Cc3ccccc3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939936 70096 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 510 7 2 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(Cc3ccccc3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
56594772 65781 0 None 15 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834750 65781 0 None 15 2 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
56594769 65726 0 None -6 2 Rabbit 9.0 pIC50 = 9.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834619 65726 0 None -6 2 Rabbit 9.0 pIC50 = 9.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
57394685 70097 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 6 2 5 1.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939937 70097 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 6 2 5 1.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(C3CC3)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
44430696 87952 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234096 87952 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity in human bradykinin B1 receptor by FLIPR methodAntagonist activity in human bradykinin B1 receptor by FLIPR method
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
11225601 142027 0 None 3 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 142027 0 None 3 2 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
46230833 199263 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 4 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL590150 199263 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 4 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
54580628 62171 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777879 62171 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11272685 62198 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777971 62198 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44587041 187877 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL496459 187877 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
54585540 62203 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777976 62203 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
46229967 199540 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 537 6 2 3 5.1 C[C@H]1CC[C@@H](C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
CHEMBL592239 199540 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 537 6 2 3 5.1 C[C@H]1CC[C@@H](C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
46230162 201317 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 6 5.2 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL604177 201317 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 548 5 2 6 5.2 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.119
46911683 15234 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 629 10 2 4 6.6 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210756 15234 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 629 10 2 4 6.6 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1016/j.bmcl.2010.06.010
57403390 70081 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 489 5 2 6 1.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCS(=O)(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939921 70081 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 489 5 2 6 1.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCS(=O)(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
57394683 70095 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 490 6 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939935 70095 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 490 6 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H]2CCN(CC(C)(C)C)CC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
44421279 85156 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225133 85156 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
46230940 200283 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 451 4 2 7 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(C)(C)C)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL597236 200283 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 451 4 2 7 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C(C)(C)C)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
44587184 170154 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL444431 170154 0 None - 1 Human 8.9 pIC50 = 8.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11284304 62199 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777972 62199 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57401663 70080 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 455 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939920 70080 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 455 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
11167607 137345 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL375288 137345 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assayAntagonist activity at bradykinin B1 receptor expressed in CHO cells assessed as inhibition of des-arg10-kallidin-induced increase in cytosolic calcium level by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
46216844 200671 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 4 5.5 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599779 200671 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 546 7 2 4 5.5 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
16102897 87239 17 None - 1 Human 8.8 pIC50 = 8.8 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 87239 17 None - 1 Human 8.8 pIC50 = 8.8 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
17751347 70113 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 4 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC3(CCN(C)C3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939953 70113 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 4 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC3(CCN(C)C3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
46230403 200336 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 458 6 2 7 4.5 CC(=O)Nn1ccnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL597546 200336 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 458 6 2 7 4.5 CC(=O)Nn1ccnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
46230459 199220 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 476 6 2 8 5.1 CC(=O)Nc1nsnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL589900 199220 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 476 6 2 8 5.1 CC(=O)Nc1nsnc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
46230352 200414 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 2 10 4.8 COc1cc(C(=O)Nn2ccnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL598147 200414 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 2 10 4.8 COc1cc(C(=O)Nn2ccnc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
44587185 188938 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL508043 188938 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11342350 62179 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777887 62179 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
46216845 200673 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 530 7 2 4 5.0 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL599780 200673 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 530 7 2 4 5.0 CCN(NC(=O)C(F)(F)F)C(=O)N[C@H](C)c1ncc(-c2cc(Cl)cc(F)c2OCC(F)F)cc1F 10.1016/j.bmcl.2009.11.119
23630715 152653 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 550 7 3 5 4.0 CN1CCC(N2CCC(CCNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
CHEMBL397248 152653 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 550 7 3 5 4.0 CN1CCC(N2CCC(CCNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
10151875 136979 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL374580 136979 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
10031511 16946 0 None 1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16946 0 None 1 2 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
23630813 151810 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 560 5 4 5 4.1 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1F 10.1021/jm051292n
CHEMBL396524 151810 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 560 5 4 5 4.1 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1F 10.1021/jm051292n
16221282 85537 0 None -13 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85537 0 None -13 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
16221111 85539 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227721 85539 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11215913 136539 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL373654 136539 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
16220918 161470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
CHEMBL412762 161470 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
44579766 193247 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 423 6 1 5 3.7 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL523773 193247 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 423 6 1 5 3.7 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
49863234 15229 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210751 15229 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44561641 186724 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488677 186724 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
11635365 174561 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
CHEMBL455642 174561 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
11635365 174561 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
CHEMBL455642 174561 0 None -2 2 Rabbit 8.0 pIC50 = 8.0 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
11214998 76555 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206247 76555 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44428100 153544 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 396 3 2 4 4.5 Cc1nc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cs1 10.1021/jm051292n
CHEMBL398008 153544 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 396 3 2 4 4.5 Cc1nc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cs1 10.1021/jm051292n
56594241 65877 0 None 4 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1835756 65877 0 None 4 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
16220987 79112 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL2113274 79112 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
54587551 62188 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777961 62188 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44580012 187046 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 495 8 1 6 4.6 CN(Cc1ccc(-c2nccs2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491041 187046 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 495 8 1 6 4.6 CN(Cc1ccc(-c2nccs2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
24946441 187134 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 6 0 6 2.9 CN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491829 187134 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 6 0 6 2.9 CN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
60142169 125900 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648460 125900 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
56835163 69568 0 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934264 69568 0 None 1 2 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
23630613 92083 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 607 8 2 7 5.4 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccn1)c1ccccc1Cl 10.1021/jm051292n
CHEMBL241937 92083 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 607 8 2 7 5.4 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccn1)c1ccccc1Cl 10.1021/jm051292n
11363856 84535 0 None -13 2 Rabbit 7.9 pIC50 = 7.9 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84535 0 None -13 2 Rabbit 7.9 pIC50 = 7.9 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
23630920 92949 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 636 9 2 7 6.0 COc1ccc(-n2nc(C(=O)NCCC3CCN(c4ccncc4)CC3)c(Br)c2NC(=O)c2ccccc2Cl)cc1 10.1021/jm051292n
CHEMBL244093 92949 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 636 9 2 7 6.0 COc1ccc(-n2nc(C(=O)NCCC3CCN(c4ccncc4)CC3)c(Br)c2NC(=O)c2ccccc2Cl)cc1 10.1021/jm051292n
17751599 70090 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939930 70090 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 420 5 3 5 0.9 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCNCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
57401425 69563 0 None -1 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934259 69563 0 None -1 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
25207727 199438 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 435 6 2 5 2.6 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
CHEMBL591354 199438 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 435 6 2 5 2.6 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
16221054 142072 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
CHEMBL387982 142072 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
11284458 140588 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
CHEMBL381366 140588 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
11284458 140588 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
CHEMBL381366 140588 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
23631903 92789 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 531 6 4 6 3.7 Nc1cccc(N2CCC(CNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)n1 10.1021/jm051292n
CHEMBL243680 92789 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 531 6 4 6 3.7 Nc1cccc(N2CCC(CNC(=O)c3n[nH]c(NC(=O)c4ccccc4Cl)c3Br)CC2)n1 10.1021/jm051292n
11284458 140588 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381366 140588 2 None - 1 Human 7.9 pIC50 = 7.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44561786 172663 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL449789 172663 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
17751422 70106 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939946 70106 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
11420875 77337 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL208387 77337 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
44579811 186867 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 1 6 2.8 CCC(NC(=O)c1nc2ccccc2n1Cc1ccccc1)C(=O)N1CCN(C2CCN(C)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL489588 186867 0 None - 1 Crab-eating macaque 5.9 pIC50 = 5.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 1 6 2.8 CCC(NC(=O)c1nc2ccccc2n1Cc1ccccc1)C(=O)N1CCN(C2CCN(C)CC2)CC1 10.1016/j.bmcl.2008.08.014
60142707 125921 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648481 125921 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
54580655 62189 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777962 62189 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57399887 70112 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 466 4 1 5 1.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2C[C@@H]3CN(C)C[C@@H]3C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939952 70112 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 466 4 1 5 1.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2C[C@@H]3CN(C)C[C@@H]3C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
56672397 65873 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human B1 receptor by cell-based assayAntagonist activity at human B1 receptor by cell-based assay
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
CHEMBL1835752 65873 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human B1 receptor by cell-based assayAntagonist activity at human B1 receptor by cell-based assay
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
57399671 69569 0 None -2 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
CHEMBL1934265 69569 0 None -2 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
44579943 186796 0 None - 1 Crab-eating macaque 7.9 pIC50 = 7.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 6 3.2 CN(Cc1ccc(C2=NCCN2C)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489191 186796 0 None - 1 Crab-eating macaque 7.9 pIC50 = 7.9 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 6 3.2 CN(Cc1ccc(C2=NCCN2C)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16108965 161330 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL412552 161330 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
16221057 143020 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389478 143020 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
16221161 144321 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL390539 144321 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
44410313 75801 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL204847 75801 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11685446 186704 0 None -14 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
CHEMBL488501 186704 0 None -14 2 Rabbit 6.9 pIC50 = 6.9 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
56594771 65780 0 None 2 2 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
CHEMBL1834749 65780 0 None 2 2 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
46230069 201025 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 555 5 2 4 5.2 CC(C)N(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
CHEMBL602320 201025 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 555 5 2 4 5.2 CC(C)N(NC(=O)c1cc(F)cc(C(F)(F)F)c1)C(=O)N[C@H](C)c1ncc(C(=O)N2[C@@H](C)CC[C@H]2C)cc1F 10.1016/j.bmcl.2009.11.119
49863229 15224 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210746 15224 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44579828 193306 0 None 1 2 Rat 7.8 pIC50 = 7.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL524126 193306 0 None 1 2 Rat 7.8 pIC50 = 7.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57399886 70108 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939948 70108 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 468 5 1 5 1.9 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
49863231 15226 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210748 15226 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44579795 186945 0 None -30 2 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490201 186945 0 None -30 2 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44579828 193306 0 None -1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL524126 193306 0 None -1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 502 7 0 6 2.8 CCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11317669 149339 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 481 5 3 4 3.2 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N1CCCCC1 10.1021/jm051292n
CHEMBL394514 149339 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 481 5 3 4 3.2 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N1CCCCC1 10.1021/jm051292n
11204003 77221 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
CHEMBL207947 77221 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
665 973 3 None -89 4 Dog 7.8 pIC50 = 7.8 Functional
Antagonist activity at dog bradykinin B1 receptorAntagonist activity at dog bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 973 3 None -89 4 Dog 7.8 pIC50 = 7.8 Functional
Antagonist activity at dog bradykinin B1 receptorAntagonist activity at dog bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 973 3 None -89 4 Dog 7.8 pIC50 = 7.8 Functional
Antagonist activity at dog bradykinin B1 receptorAntagonist activity at dog bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
44410328 76005 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL205501 76005 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
23630615 93110 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 601 10 2 7 4.5 CN(C)CCn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL244284 93110 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 601 10 2 7 4.5 CN(C)CCn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL3038104 210937 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N(CC(=O)O)C1CCCCC1 10.1021/jm950716i
16220917 166335 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL427279 166335 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221056 85559 0 None -97 2 Rabbit 5.8 pIC50 = 5.8 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85559 0 None -97 2 Rabbit 5.8 pIC50 = 5.8 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
46230834 199264 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 6 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL590151 199264 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 6 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
46230893 200372 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 7 2.4 CN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
CHEMBL597840 200372 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 4 2 7 2.4 CN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
57390932 69558 0 None 14 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934254 69558 0 None 14 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
16220916 85561 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227879 85561 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16108961 923 0 None -10 3 Rabbit 7.8 pIC50 = 7.8 Functional
Antagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 923 0 None -10 3 Rabbit 7.8 pIC50 = 7.8 Functional
Antagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 923 0 None -10 3 Rabbit 7.8 pIC50 = 7.8 Functional
Antagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rabbit bradykinin B1 receptor expressed in CHO-D cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
11526891 188878 0 None 1 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL507168 188878 0 None 1 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
16221056 85559 0 None 97 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85559 0 None 97 2 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
60141326 125946 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648506 125946 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
56594772 65781 0 None -15 2 Rabbit 7.8 pIC50 = 7.8 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834750 65781 0 None -15 2 Rabbit 7.8 pIC50 = 7.8 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
57396445 70085 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 419 5 2 4 2.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939925 70085 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 419 5 2 4 2.4 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
11213709 92323 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 475 6 4 4 3.0 NC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL242994 92323 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 475 6 4 4 3.0 NC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
16108964 141721 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385741 141721 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
57398979 70065 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)C(NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1)CCC2 10.1016/j.bmcl.2011.11.112
CHEMBL1939764 70065 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)C(NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1)CCC2 10.1016/j.bmcl.2011.11.112
44579830 186993 0 None 1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490619 186993 0 None 1 2 Crab-eating macaque 7.8 pIC50 = 7.8 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57390219 70068 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 441 5 2 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939767 70068 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 441 5 2 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
46230258 200439 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 486 6 2 7 5.2 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc(C)c1C 10.1016/j.bmcl.2009.11.120
CHEMBL598348 200439 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 486 6 2 7 5.2 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc(C)c1C 10.1016/j.bmcl.2009.11.120
11512379 166005 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
CHEMBL425416 166005 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
11342079 161786 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL414091 161786 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
57392728 69567 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934263 69567 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44579890 186616 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 534 7 1 6 3.9 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)C1CCN(C(=O)c2nc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL487909 186616 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 534 7 1 6 3.9 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)C1CCN(C(=O)c2nc3ccccc3n2Cc2ccccc2)CC1 10.1016/j.bmcl.2008.08.014
57403175 69562 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934258 69562 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
57394686 70107 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 5 1 5 2.0 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939947 70107 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 480 5 1 5 2.0 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
16221108 85531 0 None 22 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85531 0 None 22 2 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
44579969 186901 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 509 9 1 5 4.5 CN(Cc1ccc(CN2CCCCC2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489810 186901 0 None - 1 Crab-eating macaque 6.7 pIC50 = 6.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 509 9 1 5 4.5 CN(Cc1ccc(CN2CCCCC2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44580043 184742 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 460 6 1 5 3.6 O=C(NCCC(=O)N1CCC2(CCOCC2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL485079 184742 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 460 6 1 5 3.6 O=C(NCCC(=O)N1CCC2(CCOCC2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
25105469 187061 6 None -2 2 Crab-eating macaque 8.7 pIC50 = 8.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
CHEMBL491198 187061 6 None -2 2 Crab-eating macaque 8.7 pIC50 = 8.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 467 8 3 7 2.6 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc(C2=NCCN2)nc1 10.1016/j.bmcl.2008.08.014
60142027 125893 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648454 125893 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
54584600 62192 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777965 62192 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56589598 65782 0 None -7 2 Rabbit 8.7 pIC50 = 8.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834751 65782 0 None -7 2 Rabbit 8.7 pIC50 = 8.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
46230835 201001 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 439 4 2 6 4.6 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL602115 201001 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 439 4 2 6 4.6 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
25195622 62182 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
CHEMBL1777955 62182 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
54587553 62206 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777979 62206 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142441 125911 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648471 125911 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
11442712 85226 0 None -9 2 Rabbit 8.6 pIC50 = 8.6 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 85226 0 None -9 2 Rabbit 8.6 pIC50 = 8.6 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
54581666 62197 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777970 62197 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57399382 69854 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 1 5 2.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1938412 69854 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 1 5 2.3 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
60141042 125937 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
CHEMBL3648497 125937 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
11663809 173601 0 None -5 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL453339 173601 0 None -5 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
16221228 166017 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL425490 166017 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
57398239 70105 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
CHEMBL1939945 70105 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 460 5 1 5 1.5 CN(C)[C@H]1CCN(C(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2cccc(Cl)c2Cl)C1 10.1016/j.bmcl.2011.11.112
11526891 188878 0 None -1 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL507168 188878 0 None -1 2 Rabbit 7.7 pIC50 = 7.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
23630810 144502 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 452 7 3 5 3.7 O=C(NCCC1CCN(c2ccncc2)CC1)c1cc(NC(=O)c2ccccc2Cl)[nH]n1 10.1021/jm051292n
CHEMBL390692 144502 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 452 7 3 5 3.7 O=C(NCCC1CCN(c2ccncc2)CC1)c1cc(NC(=O)c2ccccc2Cl)[nH]n1 10.1021/jm051292n
137657568 159548 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1920 23 21 26 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N2 10.1021/acs.jmedchem.6b01011
CHEMBL4102547 159548 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1920 23 21 26 -5.4 CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N2 10.1021/acs.jmedchem.6b01011
16220988 85535 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
CHEMBL227697 85535 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
11405561 92207 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 354 4 3 3 3.9 Cc1c(C(=O)Nc2ccccc2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL242565 92207 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 354 4 3 3 3.9 Cc1c(C(=O)Nc2ccccc2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
16221053 142349 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL388720 142349 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
16220986 137617 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL375709 137617 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
17751868 70086 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 393 5 2 5 0.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939926 70086 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 393 5 2 5 0.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2)cc1 10.1016/j.bmcl.2011.11.112
49863230 15225 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210747 15225 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
16221226 144398 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
CHEMBL390603 144398 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
70691814 73853 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
CHEMBL2018868 73853 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
23627521 73858 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018873 73858 0 None - 1 Rat 7.7 pIC50 = 7.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
56594642 65723 0 None -21 2 Rabbit 7.7 pIC50 = 7.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834616 65723 0 None -21 2 Rabbit 7.7 pIC50 = 7.7 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
57398980 70069 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 440 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939768 70069 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 440 5 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
23630510 93297 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 446 5 3 3 4.6 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL245129 93297 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 446 5 3 3 4.6 C[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
11635364 174562 0 None -4 2 Rabbit 6.7 pIC50 = 6.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL455643 174562 0 None -4 2 Rabbit 6.7 pIC50 = 6.7 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
44410186 77217 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL207945 77217 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
16220914 85569 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL228014 85569 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44580013 187047 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 2 5 3.9 CN(Cc1ccc(-c2ccn[nH]2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491042 187047 0 None - 1 Crab-eating macaque 5.7 pIC50 = 5.7 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 2 5 3.9 CN(Cc1ccc(-c2ccn[nH]2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11444165 140879 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
CHEMBL381979 140879 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
60142024 125890 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648451 125890 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
49863233 15228 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210750 15228 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44587207 188148 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL498489 188148 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
23630811 92324 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 470 7 3 5 3.9 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1F)c1ccccc1Cl 10.1021/jm051292n
CHEMBL242995 92324 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 470 7 3 5 3.9 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1F)c1ccccc1Cl 10.1021/jm051292n
44579830 186993 0 None -1 2 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490619 186993 0 None -1 2 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 516 8 0 6 3.2 CCCN(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57394688 70110 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 5 1 5 2.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939950 70110 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 508 5 1 5 2.8 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
11307733 74896 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL203174 74896 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44579866 193186 0 None - 1 Crab-eating macaque 5.6 pIC50 = 5.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 5 0 6 3.7 O=C(c1nc2ccccc2n1Cc1ccccc1)N1CCC(C(=O)N2CCN(c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL523266 193186 0 None - 1 Crab-eating macaque 5.6 pIC50 = 5.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 5 0 6 3.7 O=C(c1nc2ccccc2n1Cc1ccccc1)N1CCC(C(=O)N2CCN(c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
54585539 62200 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777973 62200 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54585539 62200 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777973 62200 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
56835163 69568 0 None -1 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934264 69568 0 None -1 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
16220990 85546 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227786 85546 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
60142167 125897 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
CHEMBL3648458 125897 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
88925471 125905 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648465 125905 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142305 125904 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648464 125904 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44410143 77336 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
CHEMBL208386 77336 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
54587550 62186 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777959 62186 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
57390932 69558 0 None -14 2 Rabbit 6.6 pIC50 = 6.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934254 69558 0 None -14 2 Rabbit 6.6 pIC50 = 6.6 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
17751827 70088 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 421 5 2 5 1.3 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939928 70088 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 421 5 2 5 1.3 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCOCC2(C)C)cc1 10.1016/j.bmcl.2011.11.112
44561643 185648 0 None -5 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL486456 185648 0 None -5 2 Rabbit 7.6 pIC50 = 7.6 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
57391172 70084 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939924 70084 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2C)cc1 10.1016/j.bmcl.2011.11.112
71449505 80924 0 None -3 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assay
ChEMBL 475 8 1 5 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CCCc2ccc3cccnc3n2)c(F)c1 10.1016/j.bmcl.2011.04.091
CHEMBL2153436 80924 0 None -3 2 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human CHO cells assessed as inhibition of calcium flux by FLIPR assay
ChEMBL 475 8 1 5 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CCCc2ccc3cccnc3n2)c(F)c1 10.1016/j.bmcl.2011.04.091
16221225 169368 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL442056 169368 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
57401426 69566 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934262 69566 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
24946440 193052 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 6 0 6 2.4 CN1CCC(N2CCN(C(=O)CN(C)C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL522308 193052 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 6 0 6 2.4 CN1CCC(N2CCN(C(=O)CN(C)C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
44579812 187135 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 482 7 0 6 3.3 CCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491830 187135 0 None - 1 Crab-eating macaque 6.6 pIC50 = 6.6 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 482 7 0 6 3.3 CCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
57390933 69559 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934255 69559 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
46229968 201385 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 538 6 2 4 4.5 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
CHEMBL604575 201385 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 538 6 2 4 4.5 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)c(F)c1 10.1016/j.bmcl.2009.11.119
23627396 73852 0 None - 1 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018867 73852 0 None - 1 Rat 7.6 pIC50 = 7.6 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
60142166 125896 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
CHEMBL3648457 125896 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
11375297 92572 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL243467 92572 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
23630509 93270 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 453 4 4 4 2.5 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CCCCNC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL244955 93270 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 453 4 4 4 2.5 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CCCCNC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
44580044 184743 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 459 6 1 5 3.1 CN1CCC2(CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)C1 10.1016/j.bmcl.2008.08.014
CHEMBL485080 184743 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 459 6 1 5 3.1 CN1CCC2(CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)C1 10.1016/j.bmcl.2008.08.014
11620980 173712 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
CHEMBL453596 173712 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
23631902 161864 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL414892 161864 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm051292n
11215677 62184 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777957 62184 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11561240 70062 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 439 5 2 4 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939761 70062 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 439 5 2 4 2.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
16108961 923 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
664 923 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
CHEMBL415848 923 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
16108961 923 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 923 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 923 0 None 2 3 Human 8.5 pIC50 = 8.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
60142705 125919 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
CHEMBL3648479 125919 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
46230354 201463 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 3 9 5.2 COc1cc(C(=O)Nc2c[nH]nc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
CHEMBL604999 201463 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 541 8 3 9 5.2 COc1cc(C(=O)Nc2c[nH]nc2NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)on1 10.1016/j.bmcl.2009.11.120
23630919 142558 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 606 8 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccc1)c1ccccc1Cl 10.1021/jm051292n
CHEMBL389097 142558 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 606 8 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1-c1ccccc1)c1ccccc1Cl 10.1021/jm051292n
23631902 161864 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm1000776
CHEMBL414892 161864 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 530 7 3 5 4.5 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Br)c1ccccc1Cl 10.1021/jm1000776
46230889 200494 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 419 4 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(C)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL598665 200494 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 419 4 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(C)c2)no1 10.1016/j.bmcl.2009.11.121
54581664 62187 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777960 62187 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
60142439 125910 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648470 125910 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142837 125926 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648486 125926 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
11225601 142027 0 None -3 2 Rabbit 8.4 pIC50 = 8.4 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 142027 0 None -3 2 Rabbit 8.4 pIC50 = 8.4 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
46230989 200189 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 477 5 2 7 4.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL596623 200189 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 477 5 2 7 4.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)N(O)C3CCCCC3)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
11433587 15223 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210745 15223 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23630511 144775 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 486 7 3 5 4.4 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
CHEMBL390916 144775 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 486 7 3 5 4.4 O=C(Nc1[nH]nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
56835162 69564 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934260 69564 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
11519239 185760 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486640 185760 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
60142961 125927 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648487 125927 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3038096 210930 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1 10.1021/jm950716i
16108966 84379 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221925 84379 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
46230836 199265 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 389 4 2 6 3.5 Cc1nc(-c2c(F)cccc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL590153 199265 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 389 4 2 6 3.5 Cc1nc(-c2c(F)cccc2-c2cnc([C@@H](C)NC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
11203826 140122 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL380117 140122 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
56594770 65728 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834620 65728 0 None -7 2 Rabbit 7.5 pIC50 = 7.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
24946265 187064 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491219 187064 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
42605727 199408 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 8 2 5 2.1 CCN(CC)C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
CHEMBL591111 199408 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 409 8 2 5 2.1 CCN(CC)C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1016/j.bmcl.2009.11.119
57399885 70083 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCC(C)CC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939923 70083 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 405 5 2 4 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCC(C)CC2)cc1 10.1016/j.bmcl.2011.11.112
49863227 15219 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210741 15219 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
46230890 201260 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 408 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
CHEMBL603894 201260 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 408 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc(CNC(=O)N(C)O)c(F)c2)no1 10.1016/j.bmcl.2009.11.121
49863232 15227 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210749 15227 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23631015 92957 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 626 8 2 6 5.5 CN1CCC(N2CCC(CCNC(=O)c3nn(-c4ccccc4)c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
CHEMBL244124 92957 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 626 8 2 6 5.5 CN1CCC(N2CCC(CCNC(=O)c3nn(-c4ccccc4)c(NC(=O)c4ccccc4Cl)c3Br)CC2)CC1 10.1021/jm051292n
2818985 93197 5 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 431 3 2 2 6.0 CC(C)(C)c1ccc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cc1 10.1021/jm051292n
CHEMBL244522 93197 5 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 431 3 2 2 6.0 CC(C)(C)c1ccc(-c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)cc1 10.1021/jm051292n
44579913 184171 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL483036 184171 0 None - 1 Crab-eating macaque 5.5 pIC50 = 5.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
44419046 98274 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 595 10 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCc2cc(CCN3CCCCC3)ccc2C1 10.1021/jm061224g
CHEMBL274624 98274 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 595 10 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCc2cc(CCN3CCCCC3)ccc2C1 10.1021/jm061224g
659 2898 17 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
9831083 2898 17 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
CHEMBL273869 2898 17 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulationAntagonist activity at human bradykinin B1 receptor in human MR5 cells assessed as [3H]inositol phosphate accumulation
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
44579968 193124 0 None - 1 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 490 8 1 6 3.9 CN(Cc1ccc(-c2ncccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL522789 193124 0 None - 1 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 490 8 1 6 3.9 CN(Cc1ccc(-c2ncccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16220989 142499 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL389054 142499 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
60142568 125913 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648473 125913 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
56594373 65883 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1835762 65883 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
56594771 65780 0 None -2 2 Rabbit 6.5 pIC50 = 6.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
CHEMBL1834749 65780 0 None -2 2 Rabbit 6.5 pIC50 = 6.5 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
44579652 187177 0 None -57 2 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL492211 187177 0 None -57 2 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
60142963 125929 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125929 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
46230308 201586 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 5 2 4 4.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2nc3ccccc3[nH]2)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL605634 201586 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 5 2 4 4.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2nc3ccccc3[nH]2)c(F)c1 10.1016/j.bmcl.2009.11.120
46230259 200475 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 319 4 1 3 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(C)=O)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL598552 200475 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 319 4 1 3 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(C)=O)c(F)c1 10.1016/j.bmcl.2009.11.120
16220913 85551 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227828 85551 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44579829 186992 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490618 186992 0 None 1 2 Crab-eating macaque 6.5 pIC50 = 6.5 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16108967 84344 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221691 84344 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
57395451 70067 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1cccc2c1CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939766 70067 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1cccc2c1CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
57394687 70109 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 494 5 1 5 2.4 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939949 70109 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 494 5 1 5 2.4 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCC[C@H](N3CCCC3)C2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL3038105 210938 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@@H](N)C(=O)N[C@@H](CCCNC(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N(CC(=O)N1C2CCCCC2C[C@H]1C(=O)O)Cc1ccccc1 10.1021/jm950716i
11555433 188989 0 None 2 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL508632 188989 0 None 2 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
57403174 69560 0 None -5 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934256 69560 0 None -5 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
44579829 186992 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490618 186992 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 496 8 0 6 3.7 CCCN(CC(=O)N1CCN(c2ccncc2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
56835162 69564 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934260 69564 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
56594770 65728 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834620 65728 0 None 7 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assayAntagonist activity at human B1 receptor expressed in CHO cells by aequorin-based calcium flux assay
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
11663809 173601 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL453339 173601 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
16108961 923 0 None -2 3 Rat 8.4 pIC50 = 8.4 Functional
Antagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 923 0 None -2 3 Rat 8.4 pIC50 = 8.4 Functional
Antagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 923 0 None -2 3 Rat 8.4 pIC50 = 8.4 Functional
Antagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at rat bradykinin B1 receptor assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
60142302 125901 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648461 125901 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60141039 125935 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648495 125935 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
53248885 62185 0 None -18 2 Rabbit 8.4 pIC50 = 8.4 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
CHEMBL1777958 62185 0 None -18 2 Rabbit 8.4 pIC50 = 8.4 Functional
Inhibition of rabbit B1 receptor by cellular calcium flux assayInhibition of rabbit B1 receptor by cellular calcium flux assay
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
54582656 62201 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777974 62201 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11635365 174561 0 None 2 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
CHEMBL455642 174561 0 None 2 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
60141181 125938 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648498 125938 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
46230068 201048 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 527 4 2 4 4.4 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)N(C)NC(=O)c2cc(F)cc(C(F)(F)F)c2)c(F)c1 10.1016/j.bmcl.2009.11.119
CHEMBL602555 201048 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 527 4 2 4 4.4 C[C@H]1CC[C@@H](C)N1C(=O)c1cnc([C@@H](C)NC(=O)N(C)NC(=O)c2cc(F)cc(C(F)(F)F)c2)c(F)c1 10.1016/j.bmcl.2009.11.119
44561643 185648 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL486456 185648 0 None 5 2 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
60142566 125909 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648469 125909 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
46230938 201271 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 5 2 7 2.8 CCN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
CHEMBL603962 201271 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 423 5 2 7 2.8 CCN(O)C(=O)NCc1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2009.11.121
46216744 201581 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 508 6 2 7 5.7 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc2ccccc21 10.1016/j.bmcl.2009.11.120
CHEMBL605570 201581 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 508 6 2 7 5.7 CC(=O)Nn1c(NCc2ccc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)nc2ccccc21 10.1016/j.bmcl.2009.11.120
60143099 125933 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648493 125933 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
57394689 70111 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 5 1 5 2.6 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
CHEMBL1939951 70111 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 496 5 1 5 2.6 Cc1cc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N2CCCCC(N(C)C)CC2)c(C)cc1Cl 10.1016/j.bmcl.2011.11.112
60141327 125947 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
CHEMBL3648507 125947 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
57395702 70073 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 453 5 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939771 70073 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 453 5 2 5 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC(=O)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
44579889 186615 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 528 5 0 6 3.2 CN1CCC(N2CCN(C(=O)C3CCN(C(=O)c4nc5ccccc5n4Cc4ccccc4)CC3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL487908 186615 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 528 5 0 6 3.2 CN1CCC(N2CCN(C(=O)C3CCN(C(=O)c4nc5ccccc5n4Cc4ccccc4)CC3)CC2)CC1 10.1016/j.bmcl.2008.08.014
137640759 157082 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1756 21 21 23 -5.9 CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2 10.1021/acs.jmedchem.6b01011
CHEMBL4074308 157082 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL 1756 21 21 23 -5.9 CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CSSC[C@H](NC1=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2 10.1021/acs.jmedchem.6b01011
44579967 187023 0 None - 1 Crab-eating macaque 6.4 pIC50 = 6.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 489 8 1 5 4.5 CN(Cc1ccc(-c2ccccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490827 187023 0 None - 1 Crab-eating macaque 6.4 pIC50 = 6.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 489 8 1 5 4.5 CN(Cc1ccc(-c2ccccn2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44579891 192095 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 5 0 6 3.4 O=C([C@H]1CCCN1C(=O)c1nc2ccccc2n1Cc1ccccc1)N1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL520304 192095 0 None - 1 Crab-eating macaque 5.4 pIC50 = 5.4 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 5 0 6 3.4 O=C([C@H]1CCCN1C(=O)c1nc2ccccc2n1Cc1ccccc1)N1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2008.08.014
11331054 15221 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210743 15221 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
24946265 187064 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL491219 187064 0 None -1 2 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 454 6 1 6 2.6 O=C(NCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
16108962 141720 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385740 141720 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
46911684 15231 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210753 15231 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23627523 73857 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018872 73857 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
11215189 168793 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL437509 168793 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
46230306 200206 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 345 4 0 3 3.5 COC(=O)c1c(F)cccc1-c1ccc(CN2CCCC2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL596718 200206 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 345 4 0 3 3.5 COC(=O)c1c(F)cccc1-c1ccc(CN2CCCC2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
23627583 73859 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018874 73859 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
44410254 75958 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
CHEMBL205242 75958 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
44410020 138220 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL377011 138220 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
49863236 15232 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210754 15232 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
23630918 92746 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243650 92746 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(C(=O)NCCC2CCN(c3ccncc3)CC2)c(Br)c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
11635364 174562 0 None 4 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL455643 174562 0 None 4 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
44410250 75955 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
CHEMBL205227 75955 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
16108968 166138 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL426165 166138 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
16202227 73856 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018871 73856 0 None - 1 Rat 7.4 pIC50 = 7.4 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
16220915 85534 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227690 85534 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221108 85531 0 None -22 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85531 0 None -22 2 Rabbit 6.4 pIC50 = 6.4 Functional
Antagonist activity at rabbit bradykinin B1 receptorAntagonist activity at rabbit bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
60142165 125895 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
CHEMBL3648456 125895 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
CHEMBL3038103 210936 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aortaIn vitro Bradykinin receptor B1 antagonist activity in functional tissue within rabbit aorta
ChEMBL None None None NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N(CC(=O)N[C@@H](CCCN=C(N)N)C(=O)O)C1CCCCC1)C1CCCC1 10.1021/jm950716i
11478613 140591 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381372 140591 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
16221229 85568 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
CHEMBL227977 85568 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
44579850 187166 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 7 0 6 3.2 CC(C)N(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL492048 187166 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 516 7 0 6 3.2 CC(C)N(CC(=O)N1CCN(C2CCN(C)CC2)CC1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
49863237 15233 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210755 15233 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11330286 76470 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL205981 76470 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
60142026 125892 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648453 125892 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
54583583 62172 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777880 62172 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
56594241 65877 0 None -4 2 Rabbit 6.3 pIC50 = 6.3 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1835756 65877 0 None -4 2 Rabbit 6.3 pIC50 = 6.3 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
11663606 194579 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL530554 194579 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
23630513 143978 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 542 5 4 5 4.0 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL390272 143978 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 542 5 4 5 4.0 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1 10.1021/jm051292n
11224694 92766 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243667 92766 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44579795 186945 0 None 30 2 Crab-eating macaque 8.3 pIC50 = 8.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL490201 186945 0 None 30 2 Crab-eating macaque 8.3 pIC50 = 8.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 480 8 2 6 2.8 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
42606292 199539 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 519 6 2 3 5.0 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)cc1 10.1016/j.bmcl.2009.11.119
CHEMBL592238 199539 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 519 6 2 3 5.0 CC1CCC(C)N1C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(F)cc(C(F)(F)F)c3)CC2)cc1 10.1016/j.bmcl.2009.11.119
60142569 125914 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648474 125914 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
11478717 92788 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 576 5 4 5 4.6 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243679 92788 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 576 5 4 5 4.6 O=C(Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br)c1ccccc1Cl 10.1021/jm051292n
16108969 83031 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL218152 83031 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
16108969 83031 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL218152 83031 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
16108960 169259 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL441188 169259 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
60141183 125940 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
CHEMBL3648500 125940 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
11670860 185762 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486641 185762 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
42606173 199409 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 8 2 5 2.9 CC(C)N(C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1)C(C)C 10.1016/j.bmcl.2009.11.119
CHEMBL591112 199409 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 437 8 2 5 2.9 CC(C)N(C(=O)c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)CC2)cc1)C(C)C 10.1016/j.bmcl.2009.11.119
16108963 161967 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415849 161967 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
23627458 73854 0 None - 1 Rat 7.3 pIC50 = 7.3 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018869 73854 0 None - 1 Rat 7.3 pIC50 = 7.3 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
44579849 186900 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2cn[nH]c2c1 10.1016/j.bmcl.2008.08.014
CHEMBL489808 186900 0 None - 1 Crab-eating macaque 6.3 pIC50 = 6.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2cn[nH]c2c1 10.1016/j.bmcl.2008.08.014
11452874 152389 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL397037 152389 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44579865 186802 0 None - 1 Crab-eating macaque 7.3 pIC50 = 7.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 9 2 6 3.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CCNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489203 186802 0 None - 1 Crab-eating macaque 7.3 pIC50 = 7.3 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 9 2 6 3.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)CCNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11238372 169040 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL439505 169040 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
44419100 83164 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 11 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL218314 83164 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 555 11 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
44410179 166316 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL427208 166316 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
11373520 152061 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 419 4 3 4 3.7 O=C(Nc1[nH]nc(C(=O)Nc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL396735 152061 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 419 4 3 4 3.7 O=C(Nc1[nH]nc(C(=O)Nc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
16221227 143018 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
CHEMBL389477 143018 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
16221163 85571 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL228030 85571 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
46230892 200531 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 395 4 3 7 2.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)NO)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
CHEMBL598868 200531 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells assessed as inhibition of des-Arg-bradykinin-mediated calcium mobilization
ChEMBL 395 4 3 7 2.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc(CNC(=O)NO)c(F)c2)n1 10.1016/j.bmcl.2009.11.121
44410269 166134 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL426130 166134 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
44579652 187177 0 None 57 2 Crab-eating macaque 8.2 pIC50 = 8.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL492211 187177 0 None 57 2 Crab-eating macaque 8.2 pIC50 = 8.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 508 9 1 6 3.6 CCN(CC(=O)N(C)Cc1ccc(C2=NCCN2)cc1)C(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
44419045 137288 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL375229 137288 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NC1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
23630809 167360 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 451 4 3 4 2.9 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CN3CCC2CC3)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL429463 167360 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 451 4 3 4 2.9 O=C(Nc1[nH]nc(C(=O)N[C@@H]2CN3CCC2CC3)c1Br)c1ccccc1Cl 10.1021/jm051292n
16221110 85035 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL224071 85035 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221164 161746 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL413786 161746 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
24946267 186994 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 7 1 6 2.4 CN1CCC(N2CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL490626 186994 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 488 7 1 6 2.4 CN1CCC(N2CCN(C(=O)CCNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
60141184 125941 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648501 125941 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
46230307 201225 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 4 0 3 4.6 COC(=O)c1c(F)cccc1-c1ccc(CN2Cc3ccccc3C2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
CHEMBL603657 201225 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 393 4 0 3 4.6 COC(=O)c1c(F)cccc1-c1ccc(CN2Cc3ccccc3C2=O)c(F)c1 10.1016/j.bmcl.2009.11.120
44587206 188147 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL498488 188147 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cellsAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
44579945 186829 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 1 6 3.7 CN(Cc1ccc(-n2ccnc2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL489389 186829 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 478 8 1 6 3.7 CN(Cc1ccc(-n2ccnc2)cc1)C(=O)CNC(=O)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
23630612 92082 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(NC(=O)c2ccccc2Cl)c(Br)c1C(=O)NCCC1CCN(c2ccncc2)CC1 10.1021/jm051292n
CHEMBL241935 92082 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 544 7 2 6 4.5 Cn1nc(NC(=O)c2ccccc2Cl)c(Br)c1C(=O)NCCC1CCN(c2ccncc2)CC1 10.1021/jm051292n
23630814 152103 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 508 5 4 5 3.3 CC(C)C(=O)Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br 10.1021/jm051292n
CHEMBL396771 152103 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 508 5 4 5 3.3 CC(C)C(=O)Nc1[nH]nc(C(=O)NC2N=C(c3ccccc3)c3ccccc3NC2=O)c1Br 10.1021/jm051292n
57399671 69569 0 None 2 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
CHEMBL1934265 69569 0 None 2 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
11444270 76719 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
CHEMBL206554 76719 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
24755613 193126 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 474 6 1 6 2.1 CN1CCC(N2CCN(C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL522798 193126 0 None - 1 Crab-eating macaque 6.2 pIC50 = 6.2 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 474 6 1 6 2.1 CN1CCC(N2CCN(C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
16221160 97270 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL268911 97270 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
57399670 69557 0 None 13 2 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1934253 69557 0 None 13 2 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
11386138 84441 0 None -8 2 Rabbit 8.1 pIC50 = 8.1 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84441 0 None -8 2 Rabbit 8.1 pIC50 = 8.1 Functional
Activity at rabbit bradykinin B1 receptor assessed by FLIPR assayActivity at rabbit bradykinin B1 receptor assessed by FLIPR assay
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
16102899 84346 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
CHEMBL221695 84346 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
57390411 70074 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 497 5 2 6 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC3(OCCO3)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939772 70074 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 497 5 2 6 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCC3(OCCO3)c3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
46230458 199219 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 460 6 2 8 4.6 CC(=O)Nc1nonc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
CHEMBL589899 199219 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 460 6 2 8 4.6 CC(=O)Nc1nonc1NCc1ccc(-c2cc(Cl)cc(F)c2-c2noc(C)n2)cc1F 10.1016/j.bmcl.2009.11.120
11326315 150041 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 374 4 3 3 4.2 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
CHEMBL395055 150041 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 374 4 3 3 4.2 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Cl)c1ccccc1Cl 10.1021/jm051292n
44410084 76930 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL207033 76930 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
60143098 125932 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648492 125932 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
23630614 142110 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 620 9 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1Cc1ccccc1)c1ccccc1Cl 10.1021/jm051292n
CHEMBL388270 142110 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 620 9 2 6 6.0 O=C(Nc1c(Br)c(C(=O)NCCC2CCN(c3ccncc3)CC2)nn1Cc1ccccc1)c1ccccc1Cl 10.1021/jm051292n
44579944 186797 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 7 3.8 Cc1nc(-c2ccc(CN(C)C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)cc2)no1 10.1016/j.bmcl.2008.08.014
CHEMBL489192 186797 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 494 8 1 7 3.8 Cc1nc(-c2ccc(CN(C)C(=O)CNC(=O)c3nc4ccccc4n3Cc3ccccc3)cc2)no1 10.1016/j.bmcl.2008.08.014
57400697 70070 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.0 CC(=O)N1CCC(NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)c2ccccc21 10.1016/j.bmcl.2011.11.112
CHEMBL1939769 70070 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 482 5 2 5 2.0 CC(=O)N1CCC(NC(=O)C[C@@H]2C(=O)NC=CN2S(=O)(=O)c2ccc(C)cc2)c2ccccc21 10.1016/j.bmcl.2011.11.112
44410316 140863 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381964 140863 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
11691896 186705 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488512 186705 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
44580046 184248 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2nc[nH]c2c1 10.1016/j.bmcl.2008.08.014
CHEMBL483653 184248 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 438 7 3 5 3.7 O=C(CCNC(=O)c1nc2ccccc2n1Cc1ccccc1)Nc1ccc2nc[nH]c2c1 10.1016/j.bmcl.2008.08.014
60142025 125891 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648452 125891 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
57403174 69560 0 None 5 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934256 69560 0 None 5 2 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
49863235 15230 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210752 15230 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11421944 85545 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227778 85545 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
11555599 173600 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL453338 173600 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
11526655 186567 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL487823 186567 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
57398013 69561 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cc(Cl)ccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934257 69561 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cc(Cl)ccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
57402467 70066 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939765 70066 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 469 6 2 5 2.5 COc1ccc2c(c1)CCCC2NC(=O)C[C@@H]1C(=O)NC=CN1S(=O)(=O)c1ccc(C)cc1 10.1016/j.bmcl.2011.11.112
23627520 73855 0 None - 1 Rat 7.1 pIC50 = 7.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018870 73855 0 None - 1 Rat 7.1 pIC50 = 7.1 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
44410273 76715 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL206541 76715 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
11259614 93265 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 455 6 3 4 2.7 CC[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N(C)C 10.1021/jm051292n
CHEMBL244935 93265 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 455 6 3 4 2.7 CC[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)C(=O)N(C)C 10.1021/jm051292n
60142168 125898 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648459 125898 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
56951319 70087 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 392 5 3 5 0.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNCC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939927 70087 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 392 5 3 5 0.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCNCC2)cc1 10.1016/j.bmcl.2011.11.112
57395449 70063 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 413 6 2 4 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H](C)c2ccccc2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939762 70063 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 413 6 2 4 2.2 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@H](C)c2ccccc2)cc1 10.1016/j.bmcl.2011.11.112
11584184 173113 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL452057 173113 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
46230310 200205 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 569 8 2 10 5.5 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc(C)c2C)on1 10.1016/j.bmcl.2009.11.120
CHEMBL596717 200205 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilizationAntagonist activity at bradykinin B1 receptor in human IMR90 cells pretreated with IL1-beta assessed as inhibition of DAKD-induced calcium mobilization
ChEMBL 569 8 2 10 5.5 COc1cc(C(=O)Nn2c(NCc3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)nc(C)c2C)on1 10.1016/j.bmcl.2009.11.120
11555433 188989 0 None -2 2 Rabbit 7.1 pIC50 = 7.1 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL508632 188989 0 None -2 2 Rabbit 7.1 pIC50 = 7.1 Functional
Antagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at rabbit bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
9804704 93264 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 467 6 3 4 3.5 CN1CCC(CCNC(=O)c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)CC1 10.1021/jm051292n
CHEMBL244934 93264 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 467 6 3 4 3.5 CN1CCC(CCNC(=O)c2n[nH]c(NC(=O)c3ccccc3Cl)c2Br)CC1 10.1021/jm051292n
11467345 161951 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415629 161951 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilizationAntagonistic activity at human bradykinin B1 receptor expressed in CHO cells assessed as effect on DAK-mediated calcium mobilization
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
49863228 15220 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
CHEMBL1210742 15220 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
44579915 184199 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
CHEMBL483241 184199 0 None - 1 Crab-eating macaque 6.1 pIC50 = 6.1 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 514 5 0 6 2.9 CN1CCC(N2CCN(C(=O)[C@@H]3CCCN3C(=O)c3nc4ccccc4n3Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.08.014
16102920 83210 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218553 83210 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Activity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPRActivity at human bradykinin B1 receptor assessed as inhibition of Des-arg kallidin-induced increase of cytosolic calcium in CHO cells by FLIPR
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
23630512 92555 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 466 7 3 5 4.1 Cc1c(C(=O)NCCC2CCN(c3ccncc3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243208 92555 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assayAntagonist activity at human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells by FLIPR assay
ChEMBL 466 7 3 5 4.1 Cc1c(C(=O)NCCC2CCN(c3ccncc3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1021/jm051292n
16221283 85532 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227655 85532 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
16221109 144047 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL390311 144047 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
11387915 15222 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210744 15222 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
16221055 142748 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389249 142748 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
11685446 186704 0 None 14 2 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
CHEMBL488501 186704 0 None 14 2 Human 8.0 pIC50 = 8 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
57395450 70064 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 425 5 2 4 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939763 70064 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 425 5 2 4 2.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
44410026 76796 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206901 76796 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
60142833 125922 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648482 125922 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.Calcium Mobilization Assay: Calcium mobilization assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
57400937 70072 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 454 5 3 5 1.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CC(=O)Nc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939770 70072 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 454 5 3 5 1.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CC(=O)Nc3ccccc32)cc1 10.1016/j.bmcl.2011.11.112
16221162 144323 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL390540 144323 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium fluxAntagonist activity at human bradykinin B1 receptor expressed in CHOD cells assessed as effect on DAK-induced calcium flux
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44410368 76761 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206801 76761 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Inhibition of human B1 receptor by calcium influx functional assayInhibition of human B1 receptor by calcium influx functional assay
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
24946437 186774 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 7 1 6 2.9 O=C(NCCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
CHEMBL488983 186774 0 None - 1 Crab-eating macaque 6.0 pIC50 = 6.0 Functional
Antagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assayAntagonist activity at Cynomolgus monkey bradykinin B1 receptor expressed in CHO cells assessed as calcium transient by FLIPR assay
ChEMBL 468 7 1 6 2.9 O=C(NCCC(=O)N1CCN(c2ccncc2)CC1)c1nc2ccccc2n1Cc1ccccc1 10.1016/j.bmcl.2008.08.014
11605512 173603 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
CHEMBL453340 173603 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells by aquerin based assay
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
57401425 69563 0 None 1 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934259 69563 0 None 1 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assayAntagonist activity at human B1 bradykinin receptor expressed in CHO cells by aqueorin-based calcium flux assay
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
57399670 69557 0 None -13 2 Rabbit 7.0 pIC50 = 7.0 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1934253 69557 0 None -13 2 Rabbit 7.0 pIC50 = 7.0 Functional
Antagonist activity at rabbit B1 bradykinin receptor expressed in CHO cellsAntagonist activity at rabbit B1 bradykinin receptor expressed in CHO cells
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
54586518 62190 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777963 62190 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assayAntagonist activity at human bradykinin B1 receptor expressed in CHO cells assessed as inhibition of agonist-induced calcium efflux by aquerin based assay
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
642 2308 19 None 2 2 Human 6.0 pIC50 = 6 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b01011
CHEMBL384721 2308 19 None 2 2 Human 6.0 pIC50 = 6 Functional
Antagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assayAntagonist activity against bradykinin B1 receptor in human HeLa cells assessed as inhibition of Des-Arg9-BK-induced increase in intracellular Ca2+ level by Fluro-4 direct calcium dye based fluorescence assay
ChEMBL None None None None 10.1021/acs.jmedchem.6b01011
57394682 70082 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 391 5 2 4 1.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939922 70082 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysisAntagonist activity at human bradykinin B1 receptor expressed in CHO-D-/aequorin cells assessed as inhibition of DAK-induced intracellular calcium level after 1.5 to 2 hrs by luminometry analysis
ChEMBL 391 5 2 4 1.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)NC2CCCCC2)cc1 10.1016/j.bmcl.2011.11.112
44354176 96755 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 10 10 0.6 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL264517 96755 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 10 10 0.6 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354059 117059 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 34 11 10 1.8 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O 10.1021/jm980495r
CHEMBL339159 117059 0 None - 0 Rat 7.0 pKd = 7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 34 11 10 1.8 CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O 10.1021/jm980495r
44354039 115216 0 None - 0 Rat 6.0 pKd = 6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 883 27 9 10 1.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL334538 115216 0 None - 0 Rat 6.0 pKd = 6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 883 27 9 10 1.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354174 141559 0 None - 0 Rat 5.0 pKd = 5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1081 35 14 12 -1.3 NC(N)=NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C1Cc2ccccc2C1)C(=O)O 10.1021/jm980495r
CHEMBL384846 141559 0 None - 0 Rat 5.0 pKd = 5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1081 35 14 12 -1.3 NC(N)=NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](NC(=O)[C@H](CO)NC(=O)CCCCCCCCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C1Cc2ccccc2C1)C(=O)O 10.1021/jm980495r
CHEMBL133560 208720 0 None - 0 Rat 5.0 pKd = 5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCC1 10.1021/jm980495r
CHEMBL339389 211621 0 None - 0 Rat 5.9 pKd = 5.9 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
56668285 63318 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1145 26 13 15 -1.1 C=C([C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)CC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL1793829 63318 0 None - 0 Rat 6.8 pKd = 6.8 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1145 26 13 15 -1.1 C=C([C@H]1Cc2ccccc2CN1C(=O)[C@H](CO)CC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N)CCCNC(=N)N)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL2370699 209915 7 None - 0 Rat 7.7 pKd = 7.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](N)CCCN=C(N)N)C1Cc2ccccc2C1)C1Cc2ccccc2C1)C(=O)O 10.1021/jm980495r
44354162 24403 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 840 22 10 10 -1.7 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL134135 24403 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 840 22 10 10 -1.7 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354032 155747 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1037 26 12 12 -1.4 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCC(=O)NC1(C(=O)NCCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL405644 155747 0 None - 0 Rat 5.7 pKd = 5.7 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1037 26 12 12 -1.4 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCC(=O)NC1(C(=O)NCCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
44354038 19855 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 9 10 1.5 CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL130222 19855 0 None - 0 Rat 6.6 pKd = 6.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 28 9 10 1.5 CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354033 97043 0 None - 0 Rat 5.6 pKd = 5.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1009 24 12 12 -2.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCC(=O)NC1(C(=O)NCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL266975 97043 0 None - 0 Rat 5.6 pKd = 5.6 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1009 24 12 12 -2.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCC(=O)NC1(C(=O)NCCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL131647 208692 0 None - 0 Rat 5.5 pKd = 5.5 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCCC1 10.1021/jm980495r
16108961 923 0 None 2 3 Human 7.4 pKd = 7.4 Functional
Antagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical veinAntagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical vein
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 923 0 None 2 3 Human 7.4 pKd = 7.4 Functional
Antagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical veinAntagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical vein
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 923 0 None 2 3 Human 7.4 pKd = 7.4 Functional
Antagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical veinAntagonist activity at bradykinin B1 receptor assessed as prevention of Lys-desArg9-Bk-induced contraction in human umbilical vein
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
44354214 115508 0 None - 0 Rat 5.4 pKd = 5.4 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 869 24 10 10 -1.0 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL335247 115508 0 None - 0 Rat 5.4 pKd = 5.4 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 869 24 10 10 -1.0 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354175 96908 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1025 35 12 12 0.8 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@@H]1C(=O)O)C1Cc2ccccc2C1 10.1021/jm980495r
CHEMBL265814 96908 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1025 35 12 12 0.8 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@@H]1C(=O)O)C1Cc2ccccc2C1 10.1021/jm980495r
44354187 116800 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 29 11 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)O)C[C@H]2CCCC[C@H]21)C1Cc2ccccc2C1 10.1021/jm980495r
CHEMBL337833 116800 0 None - 0 Rat 6.3 pKd = 6.3 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 925 29 11 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@@H](C(=O)O)C[C@H]2CCCC[C@H]21)C1Cc2ccccc2C1 10.1021/jm980495r
CHEMBL410363 212816 24 None - 0 Rat 7.2 pKd = 7.2 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)O 10.1021/jm980495r
CHEMBL133164 208713 0 None - 0 Rat 5.2 pKd = 5.2 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NC1(C(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCCCC1 10.1021/jm980495r
CHEMBL218454 209397 0 None - 0 Rat 5.2 pKd = 5.2 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCC(=O)NC1(C(=O)NCC(=O)N[C@@H](CO)C(=O)N2Cc3ccccc3C[C@@H]2C(=O)N2[C@H](C(=O)O)C[C@@H]3CCCC[C@@H]32)CCCCCC1 10.1021/jm980495r
CHEMBL2370700 209916 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL None None None NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C1Cc2ccccc2C1)C1Cc2ccccc2C1 10.1021/jm980495r
44354179 165594 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 911 27 10 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL424272 165594 0 None - 0 Rat 7.1 pKd = 7.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 911 27 10 10 0.2 NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
44354239 141601 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1011 33 11 12 0.9 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
CHEMBL385081 141601 0 None - 0 Rat 6.1 pKd = 6.1 Functional
Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.Antagonistic activity against Bradykinin receptor B1 of rat ileum longitudinal smooth muscle.
ChEMBL 1011 33 11 12 0.9 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21 10.1021/jm980495r
11620871 166035 0 None - 0 Human 10.4 pKi = 10.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1021/jm200371q
CHEMBL425588 166035 0 None - 0 Human 10.4 pKi = 10.4 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1021/jm200371q
53248885 62185 0 None 18 2 Human 10.0 pKi = 10 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
CHEMBL1777958 62185 0 None 18 2 Human 10.0 pKi = 10 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1021/jm200808v
11342704 62183 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777956 62183 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 642 7 2 6 4.2 O=C(CC1C(=O)NCCN1S(=O)(=O)c1sc(Cl)cc1Br)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11215677 62184 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777957 62184 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 614 7 2 6 4.6 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cc2cc(Cl)ccc2s1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
44587187 188711 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL504531 188711 0 None - 1 Human 10.0 pKi = 10 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54582655 62196 0 None - 1 Human 10.0 pKi = 10.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777969 62196 0 None - 1 Human 10.0 pKi = 10.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCC(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
25195622 62182 0 None - 1 Human 9.9 pKi = 9.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
CHEMBL1777955 62182 0 None - 1 Human 9.9 pKi = 9.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 606 7 2 5 4.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2011.03.115
11215488 62181 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777954 62181 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
53248885 62185 0 None 18 2 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777958 62185 0 None 18 2 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54580628 62171 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777879 62171 0 None - 1 Human 9.8 pKi = 9.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54583617 62195 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777968 62195 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 2.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54581634 62176 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777884 62176 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 4.1 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54586519 62204 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777977 62204 0 None - 1 Human 9.7 pKi = 9.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 9 3 5 2.6 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11341479 62205 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777978 62205 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 9 3 5 2.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594769 65726 0 None 6 2 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834619 65726 0 None 6 2 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
11214819 62177 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777885 62177 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11387387 62194 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777967 62194 0 None - 1 Human 9.5 pKi = 9.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
16221282 85537 0 None 13 2 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL227713 85537 0 None 13 2 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11168954 62174 0 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777882 62174 0 None - 1 Human 9.4 pKi = 9.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1Cl)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
11342350 62179 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777887 62179 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 592 7 2 5 3.8 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54587552 62193 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777966 62193 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(C[C@@H]1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54581667 62202 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777975 62202 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 8 3 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54581635 62178 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777886 62178 0 None - 1 Human 9.3 pKi = 9.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 554 8 2 6 2.8 COc1ccc(S(=O)(=O)N2CCNC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56589598 65782 0 None 7 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834751 65782 0 None 7 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 543 5 1 6 5.2 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
54772237 65783 0 None 6 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834752 65783 0 None 6 2 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 525 5 1 6 5.0 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cn2)c(=O)c2c(F)cccc12 10.1021/jm200808v
54587514 62175 0 None - 1 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777883 62175 0 None - 1 Human 9.2 pKi = 9.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 558 7 2 5 3.4 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccc(Cl)cc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
56594642 65723 0 None 21 2 Human 9.1 pKi = 9.1 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834616 65723 0 None 21 2 Human 9.1 pKi = 9.1 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
9894973 101758 0 None - 0 Rat 9.0 pKi = 9.0 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
CHEMBL299832 101758 0 None - 0 Rat 9.0 pKi = 9.0 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
54582656 62201 0 None - 1 Human 9.0 pKi = 9.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777974 62201 0 None - 1 Human 9.0 pKi = 9.0 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 510 8 3 5 2.3 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
11364466 62173 0 None - 1 Human 8.9 pKi = 8.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777881 62173 0 None - 1 Human 8.9 pKi = 8.9 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 524 7 2 5 2.7 O=C(CC1C(=O)NCCN1S(=O)(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54587553 62206 0 None - 1 Human 8.8 pKi = 8.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777979 62206 0 None - 1 Human 8.8 pKi = 8.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 8 3 5 3.2 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594640 65721 0 None - 0 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 524 5 1 5 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)cccc12 10.1021/jm200808v
CHEMBL1834614 65721 0 None - 0 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 524 5 1 5 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)cccc12 10.1021/jm200808v
54581666 62197 0 None - 1 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777970 62197 0 None - 1 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.7 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC(C)(C)C4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
10388673 71403 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
CHEMBL195883 71403 0 None - 0 Human 7.9 pKi = 7.9 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
16221282 85537 0 None - 2 Rat 6.9 pKi = 6.9 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85537 0 None - 2 Rat 6.9 pKi = 6.9 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
16221108 85531 0 None - 2 Rat 6.8 pKi = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85531 0 None - 2 Rat 6.8 pKi = 6.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
56594371 65881 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2csc3ccccc3c2=O)c1 10.1021/jm200808v
CHEMBL1835760 65881 0 None - 0 Human 6.8 pKi = 6.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2csc3ccccc3c2=O)c1 10.1021/jm200808v
16102897 87239 17 None - 1 Rat 5.8 pKi = 5.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
CHEMBL232943 87239 17 None - 1 Rat 5.8 pKi = 5.8 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
56672397 65873 0 None - 1 Human 5.8 pKi = 5.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
CHEMBL1835752 65873 0 None - 1 Human 5.8 pKi = 5.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 432 9 1 3 5.6 O=C(CCCCC(=O)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm200808v
54580655 62189 0 None - 1 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777962 62189 0 None - 1 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 566 7 2 5 3.8 Cc1ccc(S(=O)(=O)N2CC(C)(C)NC(=O)C2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594372 65882 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2csc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835761 65882 0 None - 0 Human 7.8 pKi = 7.8 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 508 5 1 4 6.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2csc3ccccc3c2=O)cc1 10.1021/jm200808v
56594242 65878 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835757 65878 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1021/jm200808v
44569935 169492 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL443207 169492 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
56594643 65724 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cc(Cl)ccc12 10.1021/jm200808v
CHEMBL1834617 65724 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cc(Cl)ccc12 10.1021/jm200808v
11284304 62199 0 None - 1 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777972 62199 0 None - 1 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 553 7 2 6 1.8 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCN(C)CC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594772 65781 0 None 15 2 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834750 65781 0 None 15 2 Human 8.6 pKi = 8.6 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 6 5.6 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCOc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
16221056 85559 0 None - 2 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85559 0 None - 2 Rat 6.7 pKi = 6.7 Functional
Antagonist activity at rat bradykinin B1 receptorAntagonist activity at rat bradykinin B1 receptor
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
56594507 65888 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 534 6 1 5 6.3 CC(C)c1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835768 65888 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 534 6 1 5 6.3 CC(C)c1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
11284458 140588 2 None - 1 Human 7.6 pKi = 7.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
CHEMBL381366 140588 2 None - 1 Human 7.6 pKi = 7.6 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2011.03.115
44569936 173185 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL452238 173185 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
56594506 65887 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 520 6 1 5 5.7 CCc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835767 65887 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 520 6 1 5 5.7 CCc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
56658544 65874 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1)c1ccccc1 10.1021/jm200808v
CHEMBL1835753 65874 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1)c1ccccc1 10.1021/jm200808v
11272685 62198 0 None - 1 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777971 62198 0 None - 1 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 540 7 2 6 1.9 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCOCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594770 65728 0 None 7 2 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
CHEMBL1834620 65728 0 None 7 2 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 541 5 1 6 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)nc2)c(=O)c2c(Cl)cccc12 10.1021/jm200808v
56594641 65722 0 None - 0 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 5 5.8 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
CHEMBL1834615 65722 0 None - 0 Human 8.5 pKi = 8.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 542 5 1 5 5.8 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2c(F)ccc(F)c12 10.1021/jm200808v
54587550 62186 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777959 62186 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56679097 65876 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1)c1ccccc1 10.1021/jm200808v
CHEMBL1835755 65876 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1)c1ccccc1 10.1021/jm200808v
56594243 65879 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 505 5 1 4 6.0 Cn1cc(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc21 10.1021/jm200808v
CHEMBL1835758 65879 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 505 5 1 4 6.0 Cn1cc(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc21 10.1021/jm200808v
56594374 65884 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835763 65884 0 None - 0 Human 7.5 pKi = 7.5 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1021/jm200808v
11495796 73535 0 None - 0 Human 5.5 pKi = 5.5 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
CHEMBL201717 73535 0 None - 0 Human 5.5 pKi = 5.5 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm1013693
25181410 172214 1 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL447392 172214 1 None - 0 Human 7.4 pKi = 7.4 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
11635365 174561 0 None 2 2 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
CHEMBL455642 174561 0 None 2 2 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1021/jm200808v
54585540 62203 0 None - 1 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777976 62203 0 None - 1 Human 8.4 pKi = 8.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 526 7 3 5 3.0 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594768 65725 0 None - 0 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccc(Cl)cc12 10.1021/jm200808v
CHEMBL1834618 65725 0 None - 0 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 540 5 1 5 6.1 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccc(Cl)cc12 10.1021/jm200808v
56594639 65720 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 568 6 1 5 6.8 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(-c3ccccc3)c3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1834613 65720 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 568 6 1 5 6.8 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(-c3ccccc3)c3ccccc3c2=O)cc1 10.1021/jm200808v
54586518 62190 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777963 62190 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 1 5 3.4 Cc1ccc(S(=O)(=O)N2CCN(C)C(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44569938 188899 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL507546 188899 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
25181411 189293 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL512111 189293 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assayAntagonist activity at human cloned B1 receptor expressed in african green monkey COS7 cells by calcium mobilization assay
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
54584600 62192 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777965 62192 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CC(=O)NCC2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
54581664 62187 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777960 62187 0 None - 1 Human 8.3 pKi = 8.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594505 65886 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2ncc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835766 65886 0 None - 0 Human 7.3 pKi = 7.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2ncc3ccccc3c2=O)cc1 10.1021/jm200808v
54583583 62172 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
CHEMBL1777880 62172 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 462 6 2 5 1.3 CS(=O)(=O)N1CCNC(=O)C1CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2011.03.115
54587551 62188 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777961 62188 0 None - 1 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@@H]2CC(=O)N[C@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56668920 65875 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccccc1)c1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1 10.1021/jm200808v
CHEMBL1835754 65875 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 466 7 1 3 5.9 O=C(Cc1ccccc1)c1cccc(C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)c1 10.1021/jm200808v
54585539 62200 0 None - 1 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777973 62200 0 None - 1 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.03.115
56594504 65885 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2cnc3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835765 65885 0 None - 0 Human 6.2 pKi = 6.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 5 5.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2cnc3ccccc3c2=O)cc1 10.1021/jm200808v
11546560 73936 0 None - 0 Human 7.2 pKi = 7.2 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm1013693
CHEMBL202089 73936 0 None - 0 Human 7.2 pKi = 7.2 Functional
Antagonist activity at Bradykinin B1 receptorAntagonist activity at Bradykinin B1 receptor
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm1013693
56594373 65883 0 None - 1 Human 5.2 pKi = 5.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1021/jm200808v
CHEMBL1835762 65883 0 None - 1 Human 5.2 pKi = 5.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1021/jm200808v
56594241 65877 0 None 4 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1021/jm200808v
CHEMBL1835756 65877 0 None 4 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1021/jm200808v
56594771 65780 0 None 2 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
CHEMBL1834749 65780 0 None 2 2 Human 7.2 pKi = 7.2 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 507 5 1 6 4.9 Cc1nn(-c2ccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2cccnc12 10.1021/jm200808v
54581665 62191 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2(C)CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
CHEMBL1777964 62191 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptorAntagonist activity at human bradykinin B1 receptor
ChEMBL 552 7 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCNC(=O)C2(C)CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.03.115
44411297 77361 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1021/jm200371q
CHEMBL208538 77361 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assayAntagonist activity at human bradykinin B1 receptor expressed in human HEK293 cells assessed as calcium flux by FLIPR assay
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1021/jm200371q
56594508 65889 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 560 5 1 5 6.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(C(F)(F)F)c3ccccc3c2=O)cc1 10.1021/jm200808v
CHEMBL1835769 65889 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at human B1 receptorAntagonist activity at human B1 receptor
ChEMBL 560 5 1 5 6.2 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-n2nc(C(F)(F)F)c3ccccc3c2=O)cc1 10.1021/jm200808v
653 565 0 None -199 3 Mouse 6.1 pA2 = 6.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
123884 2306 14 None - 1 Mouse 6.9 pA2 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
641 2306 14 None - 1 Mouse 6.9 pA2 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
CHEMBL80472 2306 14 None - 1 Mouse 6.9 pA2 = 6.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
642 2308 19 None -2 2 Mouse 7.0 pA2 = 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
CHEMBL384721 2308 19 None -2 2 Mouse 7.0 pA2 = 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
661 3279 0 None -31 2 Mouse 7.0 pA2 = 7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8834490
663 1377 0 None - 1 Mouse 7.2 pA2 = 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
653 565 0 None -5 3 Human 7.7 pA2 = 7.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
661 3279 0 None 31 2 Human 8.5 pA2 = 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8901831
101865250 3280 0 None - 1 Human 8.6 pA2 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None NCCC[C@@H](C(=O)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)Cc1ccc2c(c1)cccc2)CO)(Cc1ccccc1)C)CCCN=C(N)N)NC(=O)C 24361511
3906 3280 0 None - 1 Human 8.6 pA2 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None NCCC[C@@H](C(=O)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)Cc1ccc2c(c1)cccc2)CO)(Cc1ccccc1)C)CCCN=C(N)N)NC(=O)C 24361511
654 566 0 None - 1 Human 9.2 pA2 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
123884 2306 14 None - 1 Mouse 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
641 2306 14 None - 1 Mouse 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
CHEMBL80472 2306 14 None - 1 Mouse 7.3 pEC50 None 7.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
642 2308 19 None 2 2 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
CHEMBL384721 2308 19 None 2 2 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
10254 2815 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 26565554
3035449 2516 0 None -39 3 Human 7.1 pIC50 None 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
638 2516 0 None -39 3 Human 7.1 pIC50 None 7.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
16108961 923 0 None -2 3 Rat 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
664 923 0 None -2 3 Rat 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
CHEMBL415848 923 0 None -2 3 Rat 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
16108961 923 0 None 2 3 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
664 923 0 None 2 3 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660
CHEMBL415848 923 0 None 2 3 Human 8.5 pIC50 None 8.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 17243660




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

135398735 136968 32 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 136968 32 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 136968 32 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
644241 95186 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 529 6 2 7 6.4 Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1 10.1038/s41467-023-40064-9
CHEMBL255863 95186 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human BDKRB1 in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 529 6 2 7 6.4 Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1 10.1038/s41467-023-40064-9
665 973 3 None - 2 Rabbit 9.6 pIC50 = 9.6 Binding
Inhibition of rabbit bradykinin B1 receptorInhibition of rabbit bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 973 3 None - 2 Rabbit 9.6 pIC50 = 9.6 Binding
Inhibition of rabbit bradykinin B1 receptorInhibition of rabbit bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 973 3 None - 2 Rabbit 9.6 pIC50 = 9.6 Binding
Inhibition of rabbit bradykinin B1 receptorInhibition of rabbit bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
122227 1378 31 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
3825 1378 31 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
644 1378 31 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
CHEMBL264100 1378 31 None 6 3 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
44579694 193143 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 7 3 5 3.6 Cc1c(C(=O)NCCC2CCN(C3CCN(C)CC3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1016/j.bmcl.2008.08.014
CHEMBL522947 193143 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 7 3 5 3.6 Cc1c(C(=O)NCCC2CCN(C3CCN(C)CC3)CC2)n[nH]c1NC(=O)c1ccccc1Cl 10.1016/j.bmcl.2008.08.014
10031511 16946 0 None 1 2 Human 8.7 pIC50 = 8.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16946 0 None 1 2 Human 8.7 pIC50 = 8.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
11204003 77221 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
CHEMBL207947 77221 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 7 2 4 6.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1C(F)(F)F 10.1016/j.bmcl.2006.01.069
44410020 138220 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL377011 138220 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 7 1 4 5.0 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CN3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
44410316 140863 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381964 140863 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2006.01.069
44410269 166134 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL426130 166134 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 569 11 2 5 5.9 CCCCOc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11215189 168793 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL437509 168793 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 9 2 4 5.6 CC(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11444270 76719 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
CHEMBL206554 76719 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 5.9 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1csc2ccccc12 10.1016/j.bmcl.2006.01.069
11444165 140879 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
CHEMBL381979 140879 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 545 7 2 4 5.7 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1Cl 10.1016/j.bmcl.2006.01.069
11512379 166005 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
CHEMBL425416 166005 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 555 7 2 7 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2nsnc12 10.1016/j.bmcl.2006.01.069
44410368 76761 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206801 76761 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 553 7 2 5 4.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11203826 140122 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL380117 140122 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 9 2 4 5.3 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
44410026 76796 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206901 76796 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 7 2 5 5.2 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
665 973 3 None -1023 2 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 973 3 None -1023 2 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 973 3 None -1023 2 Rat 6.8 pIC50 = 6.8 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
10187347 193360 0 None - 1 Human 6.8 pIC50 = 6.8 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL52498 193360 0 None - 1 Human 6.8 pIC50 = 6.8 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
44410143 77336 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
CHEMBL208386 77336 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 497 7 2 4 4.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2006.01.069
44410084 76930 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL207033 76930 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 591 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNCC(F)(F)F)ccc21 10.1016/j.bmcl.2006.01.069
10031511 16946 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16946 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
10031511 16946 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16946 0 None -1 2 Rat 8.6 pIC50 = 8.6 Binding
Inhibition of rat bradykinin B1 receptorInhibition of rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
11478613 140591 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381372 140591 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 567 10 2 5 4.6 COCCNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44410250 75955 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
CHEMBL205227 75955 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cccnc12 10.1016/j.bmcl.2006.01.069
10875606 63073 0 None - 1 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1788318 63073 0 None - 1 Human 5.7 pIC50 = 5.7 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11284458 140588 2 None - 1 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL381366 140588 2 None - 1 Human 7.6 pIC50 = 7.6 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11017305 60327 0 None - 1 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744084 60327 0 None - 1 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11071992 60325 0 None 3 2 Human 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 60325 0 None 3 2 Human 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11039234 60328 0 None -1 2 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 60328 0 None -1 2 Rat 7.6 pIC50 = 7.6 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
44455075 95352 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL256671 95352 0 None - 1 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
44410186 77217 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL207945 77217 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 615 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(C(F)(F)C(F)(F)F)cc1 10.1016/j.bmcl.2006.01.069
16726096 155268 9 None 2 4 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 155268 9 None 2 4 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
11050306 60326 0 None 1 2 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 60326 0 None 1 2 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
44455035 95724 0 None - 1 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
CHEMBL258324 95724 0 None - 1 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
44455108 155144 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL402114 155144 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
11330286 76470 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL205981 76470 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 549 8 2 4 5.1 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CC3)ccc21 10.1016/j.bmcl.2006.01.069
44410273 76715 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL206541 76715 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 531 7 2 4 5.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2006.01.069
11238372 169040 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
CHEMBL439505 169040 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 563 8 2 4 5.5 O=C(C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1)N[C@@H]1CCCc2cc(CNC3CCC3)ccc21 10.1016/j.bmcl.2006.01.069
11071992 60325 0 None -3 2 Rat 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 60325 0 None -3 2 Rat 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11307733 74896 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL203174 74896 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 579 8 2 4 6.0 CC(C)(C)CNCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44455073 95586 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL257729 95586 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
44455038 95725 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL258326 95725 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to human bradykinin B1 receptor by FLIPR assayBinding affinity to human bradykinin B1 receptor by FLIPR assay
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
44410254 75958 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
CHEMBL205242 75958 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 548 7 2 5 5.3 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc2cnccc12 10.1016/j.bmcl.2006.01.069
44410328 76005 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL205501 76005 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 537 7 1 4 4.9 CN(C)Cc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
11284303 66342 0 None -2 2 Human 5.2 pIC50 = 5.2 Binding
Inhibition of Bradykinin receptor B1 expressed in HEK293 cellsInhibition of Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL185068 66342 0 None -2 2 Human 5.2 pIC50 = 5.2 Binding
Inhibition of Bradykinin receptor B1 expressed in HEK293 cellsInhibition of Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
11039234 60328 0 None 1 2 Human 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 60328 0 None 1 2 Human 7.2 pIC50 = 7.2 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
44410179 166316 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL427208 166316 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 573 8 2 4 6.4 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.01.069
11050306 60326 0 None -1 2 Rat 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 60326 0 None -1 2 Rat 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assayCompound was tested for inhibition against rat Bradykinin receptor B1 using FLIPR assay
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
11214998 76555 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
CHEMBL206247 76555 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 551 8 2 4 5.3 CC(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2006.01.069
44410313 75801 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL204847 75801 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 527 8 2 5 4.7 COc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11017305 60327 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744084 60327 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
Compound was tested for inhibition against human bradykinin B1 receptor using FLIPR assayCompound was tested for inhibition against human bradykinin B1 receptor using FLIPR assay
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
11420875 77337 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
CHEMBL208387 77337 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of human B1 receptorInhibition of human B1 receptor
ChEMBL 511 7 2 4 5.0 Cc1ccc(S(=O)(=O)N2CCCC[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2006.01.069
11757682 122040 0 None 2 4 Human 10.8 pKd = 10.8 Binding
Equilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determinedEquilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determined
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 122040 0 None 2 4 Human 10.8 pKd = 10.8 Binding
Equilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determinedEquilibrium dissociation constant of the [35S]- radiolabeled compound against human Bradykinin receptor B1 expressed in CHO membranes was determined
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11444808 53955 0 None - 1 Human 11.0 pKi = 11 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 601 8 3 6 4.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL160547 53955 0 None - 1 Human 11.0 pKi = 11 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 601 8 3 6 4.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11757682 122040 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 122040 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity of the [35S]- radiolabeled compound to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11757682 122040 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 122040 0 None 2 4 Human 10.7 pKi = 10.7 Binding
Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rhesus monkey Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11319515 66729 0 None - 1 Human 10.7 pKi = 10.7 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 615 8 2 6 4.5 CN1CCN=C1c1ccc(CCNC(=O)C[C@@H]2C(=O)Nc3ccc(Cl)cc3N2S(=O)(=O)c2ccc3ccccc3c2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL185693 66729 0 None - 1 Human 10.7 pKi = 10.7 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 615 8 2 6 4.5 CN1CCN=C1c1ccc(CCNC(=O)C[C@@H]2C(=O)Nc3ccc(Cl)cc3N2S(=O)(=O)c2ccc3ccccc3c2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL3085458 210988 6 None 398 2 Human 10.6 pKi = 10.6 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
CHEMBL3085458 210988 6 None 398 2 Human 10.6 pKi = 10.6 Binding
Binding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligandBinding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligand
ChEMBL None None None NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990962k
665 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2004.09.074
9916412 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2004.09.074
CHEMBL189123 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2004.09.074
665 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
665 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2012.03.065
9916412 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2012.03.065
CHEMBL189123 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2012.03.065
665 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
9916412 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
CHEMBL189123 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2008.07.055
665 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
9916412 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
CHEMBL189123 973 3 None 1023 2 Human 10.5 pKi = 10.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1021/jm1000776
90662943 106584 0 None 1778 2 Human 10.5 pKi = 10.5 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1192 30 14 17 -4.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
CHEMBL3142391 106584 0 None 1778 2 Human 10.5 pKi = 10.5 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1192 30 14 17 -4.3 NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
665 973 3 None 1023 2 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 973 3 None 1023 2 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 973 3 None 1023 2 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
11620871 166035 0 None - 1 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 166035 0 None - 1 Human 10.4 pKi = 10.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11570120 70056 0 None - 1 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939755 70056 0 None - 1 Human 10.4 pKi = 10.4 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 536 7 2 5 3.5 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
665 973 3 None 1023 2 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 973 3 None 1023 2 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 973 3 None 1023 2 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
11757682 122040 0 None -2 4 Rabbit 10.3 pKi = 10.3 Binding
Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 122040 0 None -2 4 Rabbit 10.3 pKi = 10.3 Binding
Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rabbit Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11620871 166035 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 166035 0 None - 1 Human 10.3 pKi = 10.3 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11365433 66734 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 599 8 3 5 5.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL185727 66734 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 599 8 3 5 5.1 O=C(C[C@@H]1C(=O)Nc2ccc(Cl)cc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
11180561 66751 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 565 8 3 5 4.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL185811 66751 0 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 565 8 3 5 4.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(-c2ncc[nH]2)cc1 10.1016/j.bmcl.2004.09.074
11620871 166035 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 166035 0 None - 1 Human 10.1 pKi = 10.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44587187 188711 0 None - 1 Human 10.0 pKi = 10 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL504531 188711 0 None - 1 Human 10.0 pKi = 10 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 640 7 2 5 6.1 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
10288906 136398 0 None - 1 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL373530 136398 0 None - 1 Human 9.9 pKi = 9.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
44587186 172718 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL450541 172718 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 642 7 2 6 5.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
53248885 62185 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777958 62185 0 None - 1 Human 9.8 pKi = 9.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
24970287 188423 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL502140 188423 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 7 2 6 4.2 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.055
57397292 70059 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939758 70059 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 522 7 2 5 3.1 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN4CCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
16041612 172968 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL451761 172968 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
44455519 97868 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 8 2 3 5.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL272278 97868 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 8 2 3 5.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
11387624 159576 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 576 9 2 6 5.6 C[C@@H](NC(=O)C1(NC(=O)c2cc(Cl)no2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL410281 159576 0 None - 1 Human 9.7 pKi = 9.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 576 9 2 6 5.6 C[C@@H](NC(=O)C1(NC(=O)c2cc(Cl)no2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
11352746 77526 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.6 CCN1CCC(N2CCN(C(=O)COCCN(C)S(=O)(=O)c3c(C)cc(OC)cc3C)CC2)CC1 10.1021/jm2016057
CHEMBL2087422 77526 0 None - 1 Human 9.7 pKi = 9.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.6 CCN1CCC(N2CCN(C(=O)COCCN(C)S(=O)(=O)c3c(C)cc(OC)cc3C)CC2)CC1 10.1021/jm2016057
44316161 161516 0 None 1 2 Human 9.7 pKi = 9.7 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1043 25 12 16 -4.0 NCCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O 10.1021/jm990961s
CHEMBL412824 161516 0 None 1 2 Human 9.7 pKi = 9.7 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1043 25 12 16 -4.0 NCCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O 10.1021/jm990961s
122227 1378 31 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
3825 1378 31 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
644 1378 31 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
CHEMBL264100 1378 31 None 6 3 Human 9.7 pKi = 9.7 Binding
Displacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 minsDisplacement of [3H](Des-Arg10)-Kallidin from bradykinin B1 receptor in human IMR90 cells after 60 mins
ChEMBL None None None None 10.1016/j.bmcl.2013.01.025
44587189 172441 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL447870 172441 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
16108969 83031 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL218152 83031 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
44587189 172441 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
CHEMBL447870 172441 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 2 6 4.5 Cc1ccc(S(=O)(=O)N2c3ccccc3NC(=O)[C@H]2CC(=O)N[C@@H]2CCOc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.055
16108969 83031 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL218152 83031 0 None 239883 2 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
24895452 186299 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487445 186299 0 None - 1 Human 9.6 pKi = 9.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
24895452 186299 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
CHEMBL487445 186299 0 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 520 10 3 5 4.7 O=C(NCCCN1CCCCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
11848206 17097 51 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 500 3 0 4 5.4 O=C(c1cccc(N2Cc3cccc(Cl)c3C2=O)c1)N1CCC2(CC1)CCN(c1ccncc1)CC2 10.1021/jm1000776
CHEMBL1254945 17097 51 None - 1 Human 9.6 pKi = 9.6 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 500 3 0 4 5.4 O=C(c1cccc(N2Cc3cccc(Cl)c3C2=O)c1)N1CCC2(CC1)CCN(c1ccncc1)CC2 10.1021/jm1000776
11953367 17071 19 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
CHEMBL1254771 17071 19 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
44455075 95352 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL256671 95352 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 5 2 5 4.5 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
11953367 17071 19 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
CHEMBL1254771 17071 19 None 19 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
44580744 187889 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 480 5 2 8 2.9 C[C@@H](NC(=O)C1(O)CCSC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL496530 187889 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 480 5 2 8 2.9 C[C@@H](NC(=O)C1(O)CCSC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44430696 87952 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234096 87952 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
23628223 87935 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL233968 87935 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
44455268 95209 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL255997 95209 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44455087 155566 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 549 8 2 7 4.7 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(OC)no3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL404370 155566 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 549 8 2 7 4.7 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(OC)no3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
16221282 85537 0 None 316 2 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL227713 85537 0 None 316 2 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 619 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm070055c
10173772 161871 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL414962 161871 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
11283865 77538 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 523 10 0 6 3.3 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087434 77538 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 523 10 0 6 3.3 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
11442712 85226 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 85226 0 None 1 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
24884552 184295 1 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 7 4.0 C[C@@H](NC(=O)C1(O)CCC(F)(F)CC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484055 184295 1 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 7 4.0 C[C@@H](NC(=O)C1(O)CCC(F)(F)CC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44455004 97686 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 7 3.9 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1Cl 10.1016/j.bmcl.2007.11.050
CHEMBL271283 97686 0 None - 1 Human 9.4 pKi = 9.4 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 7 3.9 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1Cl 10.1016/j.bmcl.2007.11.050
16102897 87239 17 None 7 3 Human 9.4 pKi = 9.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232943 87239 17 None 7 3 Human 9.4 pKi = 9.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
44587184 170154 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL444431 170154 0 None - 1 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 9 3 6 5.3 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
16102897 87239 17 None 7 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 87239 17 None 7 3 Human 9.4 pKi = 9.4 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
16102897 87239 17 None 7 3 Human 9.4 pKi = 9.4 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
CHEMBL232943 87239 17 None 7 3 Human 9.4 pKi = 9.4 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2008.08.014
23628223 87935 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL233968 87935 0 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 6 2 4 5.0 COC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
57390218 70061 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939760 70061 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 538 8 3 5 3.7 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNCC(C)(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
44580743 192645 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 462 5 2 7 3.4 C[C@@H](NC(=O)C1(O)CCCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL521735 192645 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 462 5 2 7 3.4 C[C@@H](NC(=O)C1(O)CCCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
11757682 122040 0 None -28 4 Dog 9.3 pKi = 9.3 Binding
Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 122040 0 None -28 4 Dog 9.3 pKi = 9.3 Binding
Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to dog Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
11284564 155590 1 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 572 10 2 7 5.0 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
CHEMBL404484 155590 1 None - 1 Human 9.3 pKi = 9.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 572 10 2 7 5.0 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
11363856 84535 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84535 0 None 5 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
11225601 142027 0 None 6 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 142027 0 None 6 3 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
16726096 155268 9 None 2 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2008.07.126
CHEMBL402831 155268 9 None 2 4 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2008.07.126
10217706 83225 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
CHEMBL218605 83225 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 5 4.4 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1021/jm061094b
16102883 165866 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL424919 165866 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
57400696 70060 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939759 70060 0 None - 1 Human 9.3 pKi = 9.3 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 508 8 3 5 2.8 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CNC4CC4)ccc32)cc1 10.1016/j.bmcl.2011.11.112
10151875 136979 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL374580 136979 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 6 2 4 3.8 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
44455035 95724 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
CHEMBL258324 95724 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 7 3.4 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.11.050
10031511 16946 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16946 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
10031511 16946 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16946 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
9894973 101758 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
CHEMBL299832 101758 0 None 1 2 Human 9.2 pKi = 9.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1016/j.bmcl.2008.08.014
57383007 127209 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657638 127209 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
16747694 87953 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234097 87953 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 469 6 2 6 5.4 N#CC1(c2ccccc2C(F)(F)F)CCC(CNc2ncccc2NC(=O)c2ccno2)CC1 10.1016/j.bmcl.2007.03.059
24895550 173925 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454086 173925 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
44455090 97465 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 8 2 6 4.7 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL270173 97465 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 8 2 6 4.7 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
10239095 83915 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
CHEMBL220657 83915 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
44455038 95725 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL258326 95725 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1noc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
16726096 155268 9 None 2 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 155268 9 None 2 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
16102898 166203 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(Cl)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
CHEMBL426561 166203 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(Cl)c2-c2nnn(C)n2)cc1F 10.1021/jm061094b
44580049 184588 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 476 5 2 8 2.5 C[C@@H](NC(=O)C1(O)CCC(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484881 184588 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 476 5 2 8 2.5 C[C@@H](NC(=O)C1(O)CCC(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44593650 184591 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484882 184591 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
44432186 86698 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 6 2 4 4.5 COC(=O)c1c(F)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL231734 86698 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 6 2 4 4.5 COC(=O)c1c(F)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
10196170 136555 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL373803 136555 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11442712 85226 0 None -1 3 Rabbit 9.2 pKi = 9.2 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 85226 0 None -1 3 Rabbit 9.2 pKi = 9.2 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44580048 184143 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 9 1.6 C[C@@H](NC(=O)C1(O)CCS(=O)(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL482829 184143 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 512 5 2 9 1.6 C[C@@H](NC(=O)C1(O)CCS(=O)(=O)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
16041612 172968 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL451761 172968 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
24893993 173924 5 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454085 173924 5 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm800199h
44587183 173226 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL452331 173226 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 616 8 3 6 5.0 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
16108961 923 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
664 923 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
CHEMBL415848 923 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm070055c
11387915 15222 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210744 15222 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 10 2 4 6.4 C=C(CN1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
24893993 173924 5 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm1000776
CHEMBL454085 173924 5 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 480 8 2 6 4.4 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1)OCC1CCCO1 10.1021/jm1000776
11488817 77537 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 495 9 0 6 2.5 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087433 77537 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 495 9 0 6 2.5 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
11386138 84441 0 None 1 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84441 0 None 1 3 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
11477390 85161 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
CHEMBL225218 85161 0 None - 1 Human 9.2 pKi = 9.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1nc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)no1 10.1021/jm049394l
44411294 77333 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 450 7 2 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208371 77333 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 450 7 2 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)c(F)c1 10.1016/j.bmcl.2006.01.112
16726109 146894 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 487 6 2 5 3.7 COC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL392551 146894 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 487 6 2 5 3.7 COC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16108961 923 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
664 923 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
CHEMBL415848 923 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](c1ccccc1)NS(=O)(=O)c1ccc2c(c1)cccc2)N[C@@H]1CCOc2c1ccc(c2)CN1CCCCC1 10.1021/jm061224g
44455073 95586 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
CHEMBL257729 95586 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 5 2 6 5.0 Cc1noc(-c2c(Cl)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)n1 10.1016/j.bmcl.2007.11.050
57382836 127191 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 501 7 2 7 3.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)COC2)c(F)c1 nan
CHEMBL3657620 127191 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 501 7 2 7 3.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3ccno3)COC2)c(F)c1 nan
68869647 77527 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 10 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C4CC4)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087423 77527 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 10 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C4CC4)CC3)CC2)c(C)c1 10.1021/jm2016057
11167607 137345 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL375288 137345 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44580742 187888 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 506 6 3 7 3.7 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(CO)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL496529 187888 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 506 6 3 7 3.7 C[C@@H](NC(=O)[C@@](C)(O)C(F)(F)F)c1ncc(-c2cc(Cl)cc(F)c2-c2noc(CO)n2)cc1F 10.1016/j.bmcl.2008.07.126
44418930 83316 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL219083 83316 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 470 7 2 4 3.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
16102896 83538 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 7 2 4 4.1 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL220371 83538 0 None - 1 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 486 7 2 4 4.1 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
11281533 65077 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 65077 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11620871 166035 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 166035 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411452 76918 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207022 76918 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
665 973 3 None 1023 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
9916412 973 3 None 1023 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL189123 973 3 None 1023 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 10.1016/j.bmcl.2006.01.112
CHEMBL2369827 209694 0 None - 1 Human 9.1 pKi = 9.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCCN)C(=O)O 10.1021/jm990961s
44455574 155633 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 472 7 2 3 4.9 CCOc1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL404683 155633 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 472 7 2 3 4.9 CCOc1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
44455875 155637 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 3 5.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OC(CF)CF)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL404705 155637 0 None - 1 Human 9.1 pKi = 9.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 3 5.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OC(CF)CF)cc1F 10.1016/j.bmcl.2007.11.057
10031511 16946 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
CHEMBL1253497 16946 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm1000776
10031511 16946 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1253497 16946 0 None -1 2 Rat 9.0 pKi = 9.0 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 601 9 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
16102918 84273 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 416 6 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
CHEMBL221288 84273 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 416 6 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
44580209 184270 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 478 5 2 8 2.6 C[C@@H](NC(=O)C1(O)CCOCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL483858 184270 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 478 5 2 8 2.6 C[C@@H](NC(=O)C1(O)CCOCC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
57382837 127192 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 515 7 2 7 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(C)no3)COC2)c(F)c1 nan
CHEMBL3657621 127192 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 515 7 2 7 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cc(C)no3)COC2)c(F)c1 nan
57382923 127201 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657630 127201 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
57382925 127203 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccnnc4)COC3)c(F)c2)no1 nan
CHEMBL3657632 127203 0 None - 1 Human 9.0 pKi = 9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccnnc4)COC3)c(F)c2)no1 nan
11281533 65077 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 65077 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11320189 65485 1 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 746 17 1 8 4.5 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c(C(=O)N3CCOCC3)c2)CC1 10.1021/jm049747g
CHEMBL183048 65485 1 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 746 17 1 8 4.5 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c(C(=O)N3CCOCC3)c2)CC1 10.1021/jm049747g
70685471 73851 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.1 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018866 73851 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.1 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
44593650 184591 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL484882 184591 0 None - 1 Human 9.0 pKi = 9 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 498 5 2 7 3.6 CC(NC(=O)C1(O)CCC(F)(F)C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
11786597 67476 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 583 8 2 6 4.4 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2ccnc2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL189245 67476 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 583 8 2 6 4.4 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2ccnc2)cc1 10.1016/j.bmcl.2004.09.074
57382750 127184 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncnc4)COC3)c(F)c2)no1 nan
CHEMBL3657613 127184 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncnc4)COC3)c(F)c2)no1 nan
57382839 127194 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 10 3.2 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657623 127194 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 10 3.2 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)cn1 nan
57383057 127218 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 599 10 2 8 4.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
CHEMBL3657647 127218 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 599 10 2 8 4.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
57383099 127222 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 10 2.7 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657651 127222 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 584 8 2 10 2.7 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
44432215 86962 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 528 6 2 6 3.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL232354 86962 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 528 6 2 6 3.9 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
11444668 155544 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 586 11 2 7 5.4 CCOc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
CHEMBL404280 155544 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 586 11 2 7 5.4 CCOc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)on1 10.1016/j.bmcl.2007.11.057
11386138 84441 0 None -1 3 Rabbit 9.0 pKi = 9.0 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84441 0 None -1 3 Rabbit 9.0 pKi = 9.0 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44587185 188938 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL508043 188938 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 630 7 3 6 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11306090 85147 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 6 2 4 6.6 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1 10.1021/jm049394l
CHEMBL225006 85147 0 None - 1 Human 9.0 pKi = 9.0 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 6 2 4 6.6 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1 10.1021/jm049394l
57382924 127202 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 8 4.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
CHEMBL3657631 127202 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 8 4.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
57383053 127214 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 11 2.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
CHEMBL3657643 127214 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 585 8 2 11 2.0 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)cn1 nan
44432221 87240 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 501 7 2 5 4.1 CCOC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232945 87240 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 501 7 2 5 4.1 CCOC(=O)c1c(Cl)cccc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16202227 73856 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018871 73856 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 636 8 2 5 6.1 O=C(CC1c2cc(F)ccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
24895253 186722 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 538 10 3 5 4.7 O=C(NCCCN1CCCC(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL488662 186722 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 538 10 3 5 4.7 O=C(NCCCN1CCCC(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
44455364 155042 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccon2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL401619 155042 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 542 9 2 6 5.0 C[C@@H](NC(=O)C1(NC(=O)c2ccon2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44587181 188677 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL503847 188677 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 588 7 3 6 4.3 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
44421279 85156 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225133 85156 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 442 7 2 6 5.2 COC(=O)c1ccc(C)cc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1021/jm049394l
57398978 70058 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939757 70058 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 496 7 2 5 2.6 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN(C)C)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57382967 127208 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 554 7 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnc4)COC3)c(F)c2)no1 nan
CHEMBL3657637 127208 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 554 7 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnc4)COC3)c(F)c2)no1 nan
11281533 65077 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 65077 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
24895550 173925 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454086 173925 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
44455549 155555 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 7 2 3 5.6 CCOc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL404328 155555 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 506 7 2 3 5.6 CCOc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
11215913 136539 0 None 26915 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL373654 136539 0 None 26915 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
11017305 60327 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744084 60327 0 None - 1 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCN(c4ccncc4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
16102920 83210 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218553 83210 0 None - 1 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 500 7 2 4 4.7 CCOC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11050306 60326 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 60326 0 None 1 2 Human 8.9 pKi = 8.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
10128412 87398 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1nc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
CHEMBL233351 87398 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1nc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
57382838 127193 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 10 3.4 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
CHEMBL3657622 127193 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 10 3.4 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
57382965 127206 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 7 3 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncc(N)c4)COC3)c(F)c2)no1 nan
CHEMBL3657635 127206 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 7 3 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cncc(N)c4)COC3)c(F)c2)no1 nan
57383098 127221 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 8 2 10 2.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657650 127221 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 8 2 10 2.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
44411062 77321 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 9 1 6 5.0 CCCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208320 77321 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 9 1 6 5.0 CCCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
11307467 155223 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 6 5.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
CHEMBL402630 155223 0 None - 1 Human 8.9 pKi = 8.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 556 9 2 6 5.3 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
16102899 84346 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
CHEMBL221695 84346 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 480 5 2 2 5.0 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2C(F)(F)F)cc1F 10.1021/jm061094b
44432181 87756 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)ccc2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL233764 87756 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 6 3.7 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)ccc2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
16102907 161744 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL413775 161744 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
10233880 77454 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 714 17 3 6 4.8 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN2CCCC2)Cc2ccc(C(=N)N)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087031 77454 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 714 17 3 6 4.8 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN2CCCC2)Cc2ccc(C(=N)N)cc2)c1Cl 10.1021/jm2016057
44411358 75530 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 1 6 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL204356 75530 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 1 6 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411364 77737 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 5.0 CCC(C)N1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208991 77737 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 5.0 CCC(C)N1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
44411101 140877 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL381974 140877 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 522 8 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16102907 161744 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL413775 161744 0 None 1 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 456 6 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
44455089 97425 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 507 7 2 4 5.0 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL269963 97425 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 507 7 2 4 5.0 CCOc1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
44455366 155337 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 543 8 2 4 5.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL403202 155337 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 543 8 2 4 5.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44561786 172663 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL449789 172663 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 580 9 1 4 7.0 O=C(CC(CS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
44432212 145169 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 6 4.4 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL391227 145169 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 6 4.4 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
57382794 127186 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 512 7 2 7 3.1 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)COC2)c(F)c1 nan
CHEMBL3657615 127186 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 512 7 2 7 3.1 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)c3cncnc3)COC2)c(F)c1 nan
57382877 127195 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 575 7 2 10 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4snnc4C)COC3)c(F)c2)no1 nan
CHEMBL3657624 127195 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 575 7 2 10 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4snnc4C)COC3)c(F)c2)no1 nan
57382881 127199 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 10 2.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657628 127199 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 10 2.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
16108960 169259 0 None 30902 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL441188 169259 0 None 30902 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 567 9 2 4 6.0 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
10196170 136555 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL373803 136555 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 520 7 2 4 4.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11340940 77525 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087421 77525 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
44580047 192592 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 496 5 2 8 1.9 C[C@@H](NC(=O)C1(O)CC[S+]([O-])C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
CHEMBL521454 192592 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation countingDisplacement of [3H]des-arg10leu9kallidin from human bradykinin B1 receptor expressed in CHO cells by Wallac beta-plate scintillation counting
ChEMBL 496 5 2 8 1.9 C[C@@H](NC(=O)C1(O)CC[S+]([O-])C1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2008.07.126
57395448 70057 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1939756 70057 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 468 6 3 5 2.0 Cc1ccc(S(=O)(=O)N2C=CNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
57382922 127200 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 6 2 7 3.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
CHEMBL3657629 127200 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 6 2 7 3.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
44411054 77075 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 8 1 6 4.6 CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207378 77075 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 8 1 6 4.6 CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
44411093 140331 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL380679 140331 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
23627521 73858 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018873 73858 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 648 9 2 6 6.0 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
44587182 188690 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL504119 188690 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 602 7 2 6 4.6 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
11663809 173601 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL453339 173601 0 None - 1 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 536 8 3 6 3.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
44432222 87241 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 535 7 2 5 4.8 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232946 87241 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 535 7 2 5 4.8 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
11620238 73037 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 497 7 2 5 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncc(C(F)(F)F)c3)CC2)cc1 10.1021/jm0511280
CHEMBL201041 73037 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 497 7 2 5 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncc(C(F)(F)F)c3)CC2)cc1 10.1021/jm0511280
44455853 168715 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 560 7 2 3 6.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL436854 168715 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 560 7 2 3 6.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44587188 193371 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
CHEMBL525092 193371 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 562 7 3 6 4.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.055
71454501 79009 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 471 7 2 5 5.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL2113087 79009 0 None - 1 Human 8.7 pKi = 8.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 471 7 2 5 5.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
44432198 147309 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 2 4 5.4 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL392903 147309 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 7 2 4 5.4 CCOC(=O)c1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16726096 155268 9 None 2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to monkey bradykinin B1 receptor expressed in CHO cellsBinding affinity to monkey bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 155268 9 None 2 4 Human 8.7 pKi = 8.7 Binding
Binding affinity to monkey bradykinin B1 receptor expressed in CHO cellsBinding affinity to monkey bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
11398971 95404 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 570 10 2 6 5.5 CCc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
CHEMBL256903 95404 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 570 10 2 6 5.5 CCc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)CC2)no1 10.1016/j.bmcl.2007.11.057
16102923 84623 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 3 5.1 CCC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL222159 84623 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 3 5.1 CCC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11050306 60326 0 None -1 2 Rat 8.7 pKi = 8.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744083 60326 0 None -1 2 Rat 8.7 pKi = 8.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 606 9 2 5 6.5 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
659 2898 17 None -1 2 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
9831083 2898 17 None -1 2 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
CHEMBL273869 2898 17 None -1 2 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
9961595 64604 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 687 10 1 7 4.4 CC(C)N1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc(NCC(c4ccccc4)c4ccccc4)c(C(=O)N4CCOCC4)c3)CC2)CC1 10.1021/jm049747g
CHEMBL181695 64604 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 687 10 1 7 4.4 CC(C)N1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc(NCC(c4ccccc4)c4ccccc4)c(C(=O)N4CCOCC4)c3)CC2)CC1 10.1021/jm049747g
11377529 66704 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 706 19 2 8 3.8 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c(C(=O)N2CCOCC2)c1 10.1021/jm049747g
CHEMBL185551 66704 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 706 19 2 8 3.8 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c(C(=O)N2CCOCC2)c1 10.1021/jm049747g
11479448 127546 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 678 17 1 8 5.0 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c([N+](=O)[O-])c2)CC1 10.1021/jm049747g
CHEMBL366294 127546 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 678 17 1 8 5.0 CN(C)CCCN(CCCN(C)C)C(=O)C1CCN(S(=O)(=O)c2ccc(NCC(c3ccccc3)c3ccccc3)c([N+](=O)[O-])c2)CC1 10.1021/jm049747g
16221229 85568 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
CHEMBL227977 85568 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 10 3 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CNC3CCC3)ccc21 10.1021/jm070055c
68868975 77530 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 498 13 0 7 1.4 CCN(CC)CCN1CCN(C(=O)COCCN(C)S(=O)(=O)c2c(C)cc(OC)cc2C)CC1 10.1021/jm2016057
CHEMBL2087426 77530 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 498 13 0 7 1.4 CCN(CC)CCN1CCN(C(=O)COCCN(C)S(=O)(=O)c2c(C)cc(OC)cc2C)CC1 10.1021/jm2016057
11214151 77532 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 497 11 0 6 2.8 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(C)(C)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087428 77532 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 497 11 0 6 2.8 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(C)(C)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
16102919 83166 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 6 2 4 3.7 COC(=O)c1ccccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218319 83166 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 452 6 2 4 3.7 COC(=O)c1ccccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
10168110 77453 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 625 15 3 6 3.2 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN)CC2CCNCC2)c1Cl 10.1021/jm2016057
CHEMBL2087030 77453 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 625 15 3 6 3.2 Cc1c(Cl)ccc(S(=O)(=O)N(CCc2ccccc2)CC(=O)NCC(=O)N(CCCCN)CC2CCNCC2)c1Cl 10.1021/jm2016057
44561641 186724 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488677 186724 0 None - 1 Human 7.0 pKi = 7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
44411252 76890 0 None - 1 Human 5.0 pKi = 5 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76890 0 None - 1 Human 5.0 pKi = 5 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
10875606 63073 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1788318 63073 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
44455182 155387 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL403519 155387 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
11476944 77529 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 470 11 0 7 0.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087425 77529 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 470 11 0 7 0.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
24895114 178980 3 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(Cl)c2)cc1 10.1021/jm800199h
CHEMBL470693 178980 3 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(Cl)c2)cc1 10.1021/jm800199h
44455150 97420 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL269949 97420 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
44455227 95378 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 7 2 4 3.6 CCC(O)(CC)C(=O)NCc1ccc(-c2cccc(F)c2C(=O)OC)cc1F 10.1016/j.bmcl.2007.11.050
CHEMBL256793 95378 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 7 2 4 3.6 CCC(O)(CC)C(=O)NCc1ccc(-c2cccc(F)c2C(=O)OC)cc1F 10.1016/j.bmcl.2007.11.050
44570026 176318 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 508 11 2 5 3.3 O=C(O)CCNC(=O)CN(CCOc1cccc(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL459532 176318 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 508 11 2 5 3.3 O=C(O)CCNC(=O)CN(CCOc1cccc(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
60142437 125906 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648466 125906 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44392025 64830 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 414 7 2 6 4.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL181968 64830 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 414 7 2 6 4.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
49863235 15230 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210752 15230 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 613 10 3 4 6.7 C=C(CNC(C)(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
25181410 172214 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
CHEMBL447392 172214 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
25181410 172214 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL447392 172214 1 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
44402076 71695 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 456 7 3 4 4.9 CNC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL196494 71695 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 456 7 3 4 4.9 CNC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
44401932 71774 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 2 6 4.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL196698 71774 0 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 2 6 4.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
44402028 69822 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 3 5 4.2 Cc1ccnc(NCc2ccc(-c3ccccc3C(=O)O)cc2)c1NC(=O)CC#N 10.1016/j.bmcl.2005.02.077
CHEMBL193684 69822 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 400 7 3 5 4.2 Cc1ccnc(NCc2ccc(-c3ccccc3C(=O)O)cc2)c1NC(=O)CC#N 10.1016/j.bmcl.2005.02.077
16102908 141976 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 402 6 2 4 2.7 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
CHEMBL387331 141976 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 402 6 2 4 2.7 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(C)=O)CC2)c(F)c1 10.1021/jm061094b
60141042 125937 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
CHEMBL3648497 125937 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 537 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)COC2)no1 nan
10388673 71403 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL195883 71403 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
57382747 127181 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 7 3.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)COC3)c(F)c2)no1 nan
CHEMBL3657610 127181 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 7 3.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)COC3)c(F)c2)no1 nan
44569937 188274 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 612 13 1 6 4.6 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1 10.1016/j.bmcl.2008.11.005
CHEMBL499999 188274 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 612 13 1 6 4.6 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1 10.1016/j.bmcl.2008.11.005
57383097 127220 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 535 10 2 6 3.5 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
CHEMBL3657649 127220 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 535 10 2 6 3.5 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
11719314 140509 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 448 7 2 4 3.7 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCC2)cc1 10.1021/jm0511280
CHEMBL381009 140509 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 448 7 2 4 3.7 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCC2)cc1 10.1021/jm0511280
16102909 83332 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(C)(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL219164 83332 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(C)(Cl)Cl)CC2)c(F)c1 10.1021/jm061094b
11225601 142027 0 None -239 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 142027 0 None -239 3 Rat 6.9 pKi = 6.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
44401887 69844 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 389 7 2 5 4.5 CCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL193819 69844 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 389 7 2 5 4.5 CCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
49863229 15224 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210746 15224 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
49863230 15225 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210747 15225 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 597 10 2 4 6.0 C=C(CN1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
12085131 77458 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 8 1 5 3.5 Cc1c(Cl)ccc(S(=O)(=O)N(C)C/C=C/C(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087036 77458 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 8 1 5 3.5 Cc1c(Cl)ccc(S(=O)(=O)N(C)C/C=C/C(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
11466010 84414 0 None -1 3 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
CHEMBL221984 84414 0 None -1 3 Rat 7.9 pKi = 7.9 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
10388673 71403 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL195883 71403 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 443 7 2 5 5.0 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
60141327 125947 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
CHEMBL3648507 125947 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 554 6 2 10 3.3 Cc1nnc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)o1 nan
11685446 186704 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
CHEMBL488501 186704 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1Cl 10.1016/j.bmcl.2008.07.108
16221227 143018 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
CHEMBL389477 143018 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 614 9 3 6 5.5 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(C#N)cc1 10.1021/jm070055c
11224694 92766 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL243667 92766 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 447 6 3 4 3.4 O=C(Nc1[nH]nc(C(=O)NCCc2ccncc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44570136 183604 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 12 1 5 3.7 COCCCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL480203 183604 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 12 1 5 3.7 COCCCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
60142026 125892 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648453 125892 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 480 5 2 4 4.1 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
44455229 166883 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 363 5 2 4 2.8 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(C)(C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL428601 166883 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 363 5 2 4 2.8 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(C)(C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
44392138 122610 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 404 7 2 6 4.0 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCC1 10.1016/j.bmcl.2005.05.133
CHEMBL360260 122610 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 404 7 2 6 4.0 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCC1 10.1016/j.bmcl.2005.05.133
16221225 169368 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL442056 169368 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1Cl)c1ccccc1 10.1021/jm070055c
44401768 125521 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 418 8 2 6 3.6 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CN(C)C)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL364670 125521 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 418 8 2 6 3.6 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CN(C)C)cc1 10.1016/j.bmcl.2005.02.077
60142963 125929 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125929 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
11293092 65260 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 421 7 2 7 3.4 COC(=O)c1ccccc1N1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL182785 65260 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 421 7 2 7 3.4 COC(=O)c1ccccc1N1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
16726096 155268 9 None -15 4 Rabbit 7.9 pKi = 7.9 Binding
Binding affinity to rabbit bradykinin B1 receptor expressed in CHO cellsBinding affinity to rabbit bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 155268 9 None -15 4 Rabbit 7.9 pKi = 7.9 Binding
Binding affinity to rabbit bradykinin B1 receptor expressed in CHO cellsBinding affinity to rabbit bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
16221162 144323 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL390540 144323 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 611 9 2 5 6.7 CC1CCCC(C)N1Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11039234 60328 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 60328 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
16102882 141566 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 438 7 2 4 2.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL384893 141566 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 438 7 2 4 2.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)F)CC2)c(F)c1 10.1021/jm061094b
44392012 64881 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 419 7 2 7 3.3 COC(=O)c1ccccc1N1CC=C(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL182177 64881 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 419 7 2 7 3.3 COC(=O)c1ccccc1N1CC=C(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
44392544 126239 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 635 19 2 7 4.5 CC(=O)c1cc(S(=O)(=O)NCCC(=O)N(CCCN(C)C)CCCN(C)C)ccc1NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
CHEMBL365009 126239 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 635 19 2 7 4.5 CC(=O)c1cc(S(=O)(=O)NCCC(=O)N(CCCN(C)C)CCCN(C)C)ccc1NCC(c1ccccc1)c1ccccc1 10.1021/jm049747g
44570139 184037 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 474 11 2 5 2.7 O=C(O)CCNC(=O)CN(CCOc1ccccc1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL482173 184037 0 None - 1 Human 4.9 pKi = 4.9 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 474 11 2 5 2.7 O=C(O)CCNC(=O)CN(CCOc1ccccc1)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
16108968 166138 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL426165 166138 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
16221163 85571 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL228030 85571 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/jm070055c
44432176 87276 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1cc(Cl)ccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL233150 87276 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1cc(Cl)ccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
70683374 73849 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 6.8 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018864 73849 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 6.8 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
16220914 85569 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL228014 85569 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 529 9 3 5 4.6 CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11584184 173113 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL452057 173113 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 500 8 3 6 2.7 Cc1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
44430680 142076 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 416 6 2 4 5.0 N#CC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL388029 142076 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 416 6 2 4 5.0 N#CC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16221056 85559 0 None 14 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227870 85559 0 None 14 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.6 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
49863228 15220 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
CHEMBL1210742 15220 0 None - 1 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 639 10 2 4 6.8 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1)N[C@@H]1CCCc2cc(C3(CN4CCCCC4)CC3)ccc21 10.1016/j.bmcl.2010.06.010
57382966 127207 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnn4)COC3)c(F)c2)no1 nan
CHEMBL3657636 127207 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 555 7 2 9 3.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cccnn4)COC3)c(F)c2)no1 nan
11422305 63759 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 638 19 2 8 4.2 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL180143 63759 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 638 19 2 8 4.2 CN(C)CCCN(CCCN(C)C)C(=O)CCNS(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
70691811 73842 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 489 5 2 4 4.5 O=C(CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccccc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018857 73842 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 489 5 2 4 4.5 O=C(CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccccc1 10.1016/j.bmcl.2012.03.065
10166801 102783 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 569 8 1 5 6.3 O=C(CCCN1C(=O)CN=C(C2CCCCC2)c2ccccc21)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1021/jm034020y
CHEMBL30525 102783 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 569 8 1 5 6.3 O=C(CCCN1C(=O)CN=C(C2CCCCC2)c2ccccc21)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1021/jm034020y
44392040 172880 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL451549 172880 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
57343016 77520 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 480 10 1 6 1.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(F)cccc1F 10.1021/jm2016057
CHEMBL2087416 77520 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 480 10 1 6 1.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(F)cccc1F 10.1021/jm2016057
16108963 161967 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415849 161967 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
44430679 142553 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 421 7 2 4 5.1 COC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL389094 142553 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 421 7 2 4 5.1 COC1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
60142025 125891 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648452 125891 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 7 2 3 5.6 O=C(NC1(C(=O)NC2CCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
44569938 188899 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL507546 188899 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 629 14 1 7 4.7 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCOCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
57399671 69569 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
CHEMBL1934265 69569 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 4 6.6 Cc1cccc2occ(-c3ccc(C(=O)N[C@H]4CCCc5cc(CN6CCCCC6)ccc54)cc3)c(=O)c12 10.1016/j.bmcl.2011.10.068
24895455 186424 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 479 8 3 5 4.0 O=C(NCC1CCCO1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487621 186424 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 479 8 3 5 4.0 O=C(NCC1CCCO1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
12085130 77456 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 8 1 5 3.3 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087034 77456 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 8 1 5 3.3 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
60142835 125924 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648484 125924 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 7 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
23627520 73855 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018870 73855 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 580 9 2 6 4.7 COc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
16108965 161330 0 None 1000 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
CHEMBL412552 161330 0 None 1000 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 646 9 2 6 4.9 CN1c2cc(CN3CCCCC3)ccc2[C@H](NC(=O)C[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)c2ccccc2)CS1(=O)=O 10.1021/jm061224g
44561643 185648 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL486456 185648 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 542 8 3 6 3.7 CC(C)(C)c1ccc(S(=O)(=O)C[C@@H](O)[C@@H](O)C(=O)N[C@@H]2CCCc3cc(CN4CCCCC4)ccc32)cc1 10.1016/j.bmcl.2008.07.108
60143098 125932 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648492 125932 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 428 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(N)CC2)no1 nan
44570137 190977 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 518 11 2 7 2.4 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL518616 190977 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 518 11 2 7 2.4 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
11604201 73331 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 422 7 2 4 3.2 COC(=O)c1ccccc1-c1ccc(CNC(=O)[C@@H](C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL201310 73331 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 422 7 2 4 3.2 COC(=O)c1ccccc1-c1ccc(CNC(=O)[C@@H](C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
49863234 15229 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210751 15229 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 12 3 4 6.3 C=C(CNCC1CC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11526891 188878 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL507168 188878 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.7 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.108
57396212 69565 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccc(Cl)cc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934261 69565 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccc(Cl)cc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
11676747 87891 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 449 7 2 5 4.7 COC(=O)C1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL233873 87891 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 449 7 2 5 4.7 COC(=O)C1(c2ccccc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16102897 87239 17 None -1737 3 Rat 5.8 pKi = 5.8 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 87239 17 None -1737 3 Rat 5.8 pKi = 5.8 Binding
Binding affinity to rat bradykinin B1 receptorBinding affinity to rat bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
70693872 73847 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 587 8 1 6 4.2 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCN1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018862 73847 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 587 8 1 6 4.2 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCN1CCN(c2ccncc2)CC1 10.1016/j.bmcl.2012.03.065
11555599 173600 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL453338 173600 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@H](CCS(=O)(=O)c1ccc2ccccc2c1)C(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
56835163 69568 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934264 69568 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(F)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44411355 76804 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 6 1 6 3.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206935 76804 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 6 1 6 3.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11039234 60328 0 None -1 2 Rat 7.8 pKi = 7.8 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
CHEMBL1744085 60328 0 None -1 2 Rat 7.8 pKi = 7.8 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 592 7 2 5 6.2 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(c2ccc(C)cc2)c2ccccc21 10.1021/jm034020y
16108966 84379 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221925 84379 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 555 10 2 4 6.1 C[C@@H](NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)c1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
16108962 141720 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385740 141720 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
60142836 125925 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
CHEMBL3648485 125925 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 8 4.7 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)on1 nan
11421944 85545 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227778 85545 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/jm070055c
88925471 125905 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648465 125905 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 3.5 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
44430681 87998 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccccc2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234296 87998 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccccc2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
11071992 60325 0 None -3 2 Rat 7.7 pKi = 7.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 60325 0 None -3 2 Rat 7.7 pKi = 7.7 Binding
Compound was tested for inhibition against rat Bradykinin receptor B1Compound was tested for inhibition against rat Bradykinin receptor B1
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
60142834 125923 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
CHEMBL3648483 125923 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 580 7 2 8 4.5 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cc(F)c43)CC2)cn1 nan
57401425 69563 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934259 69563 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3ccccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44411050 77203 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 453 7 1 6 4.3 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207922 77203 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 453 7 1 6 4.3 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895252 186296 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 452 9 4 5 3.1 CNCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL1203967 186296 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 452 9 4 5 3.1 CNCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487444 186296 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 452 9 4 5 3.1 CNCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
60143099 125933 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648493 125933 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 534 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
11519239 185760 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486640 185760 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
57383009 127211 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 8 2 4 5.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657640 127211 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 8 2 4 5.1 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
16108964 141721 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL385741 141721 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 583 9 2 5 5.9 O=C(C[C@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCOc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
24970503 169777 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 576 10 2 7 3.4 COc1cc2c(cc1OC)C(CC(=O)NCCc1ccc(C3=NCCN3)cc1)N(S(=O)(=O)c1ccc(C)cc1)CC2 10.1016/j.ejmech.2007.10.030
CHEMBL443900 169777 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 576 10 2 7 3.4 COc1cc2c(cc1OC)C(CC(=O)NCCc1ccc(C3=NCCN3)cc1)N(S(=O)(=O)c1ccc(C)cc1)CC2 10.1016/j.ejmech.2007.10.030
44392068 64811 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 442 7 2 7 4.8 Cc1noc([C@H]2CC=CC[C@@H]2c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)n1 10.1016/j.bmcl.2005.05.133
CHEMBL181961 64811 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 442 7 2 7 4.8 Cc1noc([C@H]2CC=CC[C@@H]2c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)n1 10.1016/j.bmcl.2005.05.133
44430686 142078 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 452 6 2 4 5.3 N#CC1(c2cccc(F)c2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL388031 142078 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 452 6 2 4 5.3 N#CC1(c2cccc(F)c2F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16102897 87239 17 None 7 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to rhesus monkey bradykinin B1 receptorBinding affinity to rhesus monkey bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 87239 17 None 7 3 Human 8.7 pKi = 8.7 Binding
Binding affinity to rhesus monkey bradykinin B1 receptorBinding affinity to rhesus monkey bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
11259064 137126 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 433 6 2 5 5.4 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C#N)cc1 10.1021/jm049394l
CHEMBL374779 137126 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 433 6 2 5 5.4 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2C#N)cc1 10.1021/jm049394l
10128103 145523 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL391491 145523 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1ccc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
16041612 172968 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL451761 172968 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 499 8 2 7 4.0 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1)OCC1CCCO1 10.1021/jm800199h
24895454 186598 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 522 10 3 6 3.6 O=C(NCCCN1CCOCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487876 186598 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 522 10 3 6 3.6 O=C(NCCCN1CCOCC1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
57342336 77457 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 526 10 1 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087035 77457 0 None - 1 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 526 10 1 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
16726096 155268 9 None -2 4 Rat 8.7 pKi = 8.7 Binding
Binding affinity to rat bradykinin B1 receptor expressed in CHO cellsBinding affinity to rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 155268 9 None -2 4 Rat 8.7 pKi = 8.7 Binding
Binding affinity to rat bradykinin B1 receptor expressed in CHO cellsBinding affinity to rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
57383010 127212 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 11 2.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
CHEMBL3657641 127212 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 574 8 2 11 2.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4nnn(C)n4)cc3F)COC2)on1 nan
44392156 64942 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.3 COC(=O)C1CCCCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182275 64942 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.3 COC(=O)C1CCCCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
44411095 168818 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 7 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL437704 168818 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 508 7 1 6 4.6 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
70695989 73846 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.4 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018861 73846 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.4 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
57383008 127210 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 9 2 6 4.8 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657639 127210 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 9 2 6 4.8 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ccc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
44455492 95078 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 7 2 3 6.0 CC(C)Oc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
CHEMBL255325 95078 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 520 7 2 3 6.0 CC(C)Oc1c(Cl)cc(Cl)cc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.11.057
57382748 127182 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 7 2 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccno4)COC3)c(F)c2)no1 nan
CHEMBL3657611 127182 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 544 7 2 9 3.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4ccno4)COC3)c(F)c2)no1 nan
44432207 87237 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 5 5.5 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
CHEMBL232933 87237 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 6 2 5 5.5 Cc1nc(-c2c(Cl)cc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)no1 10.1016/j.bmcl.2007.04.040
57382749 127183 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 9 3.7 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
CHEMBL3657612 127183 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 7 2 9 3.7 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(F)c4-c4noc(C)n4)cc3F)COC2)on1 nan
16102884 83156 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 472 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218267 83156 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 472 7 2 4 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)Cl)CC2)c(F)c1 10.1021/jm061094b
57523216 125916 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648476 125916 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 562 7 2 8 4.4 COc1ncc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
57382746 127180 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 639 7 2 7 5.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cc(F)cc(C(F)(F)F)c4)COC3)c(F)c2)no1 nan
CHEMBL3657609 127180 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 639 7 2 7 5.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cc(F)cc(C(F)(F)F)c4)COC3)c(F)c2)no1 nan
57382835 127190 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 9 2 7 4.0 C[C@@H](NC(=O)C1(NC(=O)c2cncnc2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657619 127190 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 569 9 2 7 4.0 C[C@@H](NC(=O)C1(NC(=O)c2cncnc2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
44432220 87201 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 521 6 2 5 4.4 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
CHEMBL232750 87201 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 521 6 2 5 4.4 COC(=O)c1c(Cl)cc(Cl)cc1-c1cnc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1016/j.bmcl.2007.04.040
24895550 173925 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
CHEMBL454086 173925 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 481 8 2 7 3.8 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1)OCC1CCCO1 10.1021/jm800199h
11456015 155377 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 582 10 2 6 5.8 C[C@@H](NC(=O)C1(NC(=O)c2cc(C3CC3)on2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
CHEMBL403434 155377 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in rat CNSBinding affinity to human bradykinin B1 receptor expressed in rat CNS
ChEMBL 582 10 2 6 5.8 C[C@@H](NC(=O)C1(NC(=O)c2cc(C3CC3)on2)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F 10.1016/j.bmcl.2007.11.057
44587041 187877 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL496459 187877 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 574 6 3 6 4.0 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
71454502 79012 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 428 7 2 6 4.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL2113091 79012 0 None - 1 Human 8.6 pKi = 8.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 428 7 2 6 4.9 COC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.02.077
11363856 84535 0 None -5 3 Rabbit 8.6 pKi = 8.6 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84535 0 None -5 3 Rabbit 8.6 pKi = 8.6 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
44411442 140436 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 5.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL380920 140436 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 5.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCCCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16102885 83209 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 454 7 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)Cl)CC2)c(F)c1 10.1021/jm061094b
CHEMBL218552 83209 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 454 7 2 4 3.2 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)Cl)CC2)c(F)c1 10.1021/jm061094b
57342845 77513 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.4 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C(F)(F)F 10.1021/jm2016057
CHEMBL2087409 77513 0 None - 1 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.4 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C(F)(F)F 10.1021/jm2016057
44411353 75565 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL204562 75565 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
70691814 73853 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
CHEMBL2018868 73853 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 592 8 2 5 5.6 Cc1cc(C)c(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1C 10.1016/j.bmcl.2012.03.065
16102881 83357 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL219309 83357 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 506 7 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(NC(=O)C(F)(F)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
60142027 125893 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648454 125893 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
16221054 142072 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
CHEMBL387982 142072 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 591 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cc(Cl)c(F)cc1F)c1ccccc1 10.1021/jm070055c
11452874 152389 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
CHEMBL397037 152389 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 418 4 3 3 4.3 O=C(Nc1[nH]nc(C(=O)Nc2ccccc2)c1Br)c1ccccc1Cl 10.1021/jm051292n
44402075 72009 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1021/jm049394l
CHEMBL197462 72009 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1021/jm049394l
44402075 72009 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL197462 72009 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 417 9 2 5 5.3 CCCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
24895354 178890 3 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1 10.1021/jm800199h
CHEMBL469875 178890 3 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccn2)cc1 10.1021/jm800199h
16726096 155268 9 None -239 4 Dog 6.7 pKi = 6.7 Binding
Binding affinity to dog bradykinin B1 receptor expressed in CHO cellsBinding affinity to dog bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
CHEMBL402831 155268 9 None -239 4 Dog 6.7 pKi = 6.7 Binding
Binding affinity to dog bradykinin B1 receptor expressed in CHO cellsBinding affinity to dog bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 5 2 6 4.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)[C@@](C)(O)C(F)(F)F)c(F)c2)no1 10.1016/j.bmcl.2007.11.050
49863232 15227 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210749 15227 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 601 12 4 5 4.9 C=C(CNCCO)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
44569935 169492 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL443207 169492 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 646 13 1 6 5.3 CC(C)COc1ccc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Cl 10.1016/j.bmcl.2008.11.005
16221160 97270 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
CHEMBL268911 97270 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 597 10 3 5 6.3 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CNC3CCCCC3)ccc21 10.1021/jm070055c
44569939 178730 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 580 12 1 7 4.2 COc1ccccc1CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL468492 178730 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 580 12 1 7 4.2 COc1ccccc1CCNC(=O)CN(CCOc1ccc2c(c1)OCO2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
60141184 125941 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648501 125941 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 7 2.3 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)n1 nan
44410972 77278 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCOCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208086 77278 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCOCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
60142305 125904 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648464 125904 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44411349 140364 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 550 6 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)C(C)(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL380834 140364 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 550 6 1 6 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)C(C)(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895450 191391 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 423 6 2 4 3.8 CN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL519247 191391 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 423 6 2 4 3.8 CN(C)C(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
24895186 186177 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 409 6 3 4 3.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487263 186177 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 409 6 3 4 3.5 CNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
60142024 125890 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648451 125890 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 446 5 2 4 3.5 COC(=O)c1ccccc1-c1ccc2c(c1)CCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
10311064 77984 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL2096845 77984 0 None - 1 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 484 7 2 4 4.2 COC(=O)c1c(F)cccc1-c1ccc([C@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
44570138 183605 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 456 8 1 4 3.3 CNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL480204 183605 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 456 8 1 4 3.3 CNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
44411360 76882 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 7 1 7 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(S(C)(=O)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206982 76882 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 544 7 1 7 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(S(C)(=O)=O)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895351 189858 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2)cc1 10.1021/jm800199h
CHEMBL516783 189858 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2)cc1 10.1021/jm800199h
11284458 140588 2 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
CHEMBL381366 140588 2 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 565 7 2 4 5.7 CC(C)(C)NCc1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H]1CCCCN1S(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.055
11670860 185762 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL486641 185762 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)CCS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
60141039 125935 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648495 125935 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 553 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
11376509 64316 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 567 16 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL181098 64316 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 567 16 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NCC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
44401703 133478 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 7 2 5 4.7 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)C(C)C)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL370704 133478 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 7 2 5 4.7 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)C(C)C)cc1 10.1016/j.bmcl.2005.02.077
70695304 77450 0 None -17 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 556 8 2 6 4.0 Cc1ccc2cccc(OCc3cc(S(=O)(=O)N4CCC[C@H]4C(=O)NCC4CCNCC4)ccc3Cl)c2n1 10.1021/jm2016057
CHEMBL2087027 77450 0 None -17 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 556 8 2 6 4.0 Cc1ccc2cccc(OCc3cc(S(=O)(=O)N4CCC[C@H]4C(=O)NCC4CCNCC4)ccc3Cl)c2n1 10.1021/jm2016057
70688994 77451 0 None 18 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 433 5 2 4 2.6 Cc1c(Cl)ccc(S(=O)(=O)N2CCC[C@H]2C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
CHEMBL2087028 77451 0 None 18 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 433 5 2 4 2.6 Cc1c(Cl)ccc(S(=O)(=O)N2CCC[C@H]2C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
60142168 125898 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL3648459 125898 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 7 2 3 6.0 O=C(NC1(C(=O)NC2CCCc3cc(-c4cc(Cl)cc(Cl)c4OCC(F)F)ccc32)CC1)C(F)(F)F nan
CHEMBL2369828 209695 0 None - 1 Human 7.6 pKi = 7.6 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None NC(N)=NCCC[C@H](NC(=O)[C@H](N)CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](Cc1cccs1)C(=O)N[C@@H](CO)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)N1c2ccccc2C[C@H]1C(=O)O 10.1021/jm990961s
60142439 125910 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648470 125910 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
24895256 186422 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 453 9 3 5 3.5 COCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL487620 186422 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 453 9 3 5 3.5 COCCNC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
24895184 194578 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1 10.1021/jm800199h
CHEMBL530549 194578 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cn2)cc1 10.1021/jm800199h
9919335 106585 1 None 489 2 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligandBinding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligand
ChEMBL 922 22 9 13 -2.1 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC2(CC1)C(=O)N(CC(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc3ccccc3N(CC(=O)O)C1=O)CN2CCc1ccccc1 10.1021/jm990962k
CHEMBL3142392 106585 1 None 489 2 Human 7.6 pKi = 7.6 Binding
Binding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligandBinding affinity towards human cloned B1 receptor was determined using [3H][des-Arg10-Leu9]-kallidin as radioligand
ChEMBL 922 22 9 13 -2.1 NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC2(CC1)C(=O)N(CC(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc3ccccc3N(CC(=O)O)C1=O)CN2CCc1ccccc1 10.1021/jm990962k
44430684 88044 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2cccc(C(F)(F)F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234512 88044 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.1 N#CC1(c2cccc(C(F)(F)F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
44455108 155144 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL402114 155144 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
16221164 161746 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL413786 161746 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 577 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(C)(C)C)cc1)c1ccccc1 10.1021/jm070055c
57382878 127196 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 521 8 2 8 2.7 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)COC1 nan
CHEMBL3657625 127196 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 521 8 2 8 2.7 COCC(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(F)c3-c3noc(C)n3)cc2F)COC1 nan
44392045 131783 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.3 COC(=O)c1ccccc1C1=CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL369307 131783 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.3 COC(=O)c1ccccc1C1=CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
44411347 76888 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 7 1 6 3.8 C#CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207000 76888 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 504 7 1 6 3.8 C#CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
16221053 142349 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL388720 142349 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 573 9 3 5 5.4 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(F)c(Cl)c1)c1ccccc1 10.1021/jm070055c
11575578 73937 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 430 7 2 6 2.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1021/jm0511280
CHEMBL202090 73937 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 430 7 2 6 2.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)c3cncnc3)CC2)cc1 10.1021/jm0511280
60141181 125938 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648498 125938 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 6 2 8 4.1 Cc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
44391977 122773 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 403 7 2 7 3.4 COC(=O)c1cccn1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL360500 122773 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 403 7 2 7 3.4 COC(=O)c1cccn1-c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11180748 168342 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 581 17 1 7 4.8 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(Cc2ccccc2)Cc2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL434341 168342 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 581 17 1 7 4.8 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(Cc2ccccc2)Cc2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
24895111 176720 3 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2F)cc1 10.1021/jm800199h
CHEMBL460045 176720 3 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2F)cc1 10.1021/jm800199h
44411080 166226 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 556 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(Cc4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL426681 166226 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 556 8 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(Cc4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
60141326 125946 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
CHEMBL3648506 125946 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 7 3.1 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(N)CC2)n1 nan
16220987 79112 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL2113274 79112 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/jm070055c
44411071 76881 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 530 8 1 6 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206975 76881 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 530 8 1 6 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895182 178864 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2F)cc1 10.1021/jm800199h
CHEMBL469675 178864 3 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2F)cc1 10.1021/jm800199h
10187347 193360 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL52498 193360 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 544 7 2 5 5.5 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(N(C)C)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
44411252 76890 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76890 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human BK1 receptor E273 mutantBinding affinity to human BK1 receptor E273 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
57390932 69558 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934254 69558 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3cccc(Cl)c3c2=O)c1 10.1016/j.bmcl.2011.10.068
60142962 125928 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
CHEMBL3648488 125928 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 9 4.0 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)on1 nan
88574592 127197 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 588 10 2 8 4.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
CHEMBL3657626 127197 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 588 10 2 8 4.2 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
11225601 142027 0 None -6 3 Rabbit 8.5 pKi = 8.5 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
CHEMBL387638 142027 0 None -6 3 Rabbit 8.5 pKi = 8.5 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnn(C)n2)cc1 10.1021/jm049394l
60142570 125915 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
CHEMBL3648475 125915 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)CC2)no1 nan
23627396 73852 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018867 73852 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 618 8 2 5 6.0 O=C(CC1c2ccccc2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
57342494 77515 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1cccc(Cl)c1Cl 10.1021/jm2016057
CHEMBL2087411 77515 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1cccc(Cl)c1Cl 10.1021/jm2016057
57383011 127213 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 598 10 2 7 4.6 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
CHEMBL3657642 127213 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 598 10 2 7 4.6 COc1ncc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)cn1 nan
44411368 77152 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.8 C/C=C/CN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207800 77152 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 8 1 6 4.8 C/C=C/CN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
11331054 15221 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210743 15221 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 10 2 4 6.8 C=C(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
68869570 77524 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 9 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CC4CCC(C3)N4C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087420 77524 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 522 9 0 7 1.7 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CC4CCC(C3)N4C)CC2)c(C)c1 10.1021/jm2016057
44411457 76712 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 8 1 6 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL206519 76712 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 534 8 1 6 5.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC4CCC4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411051 77074 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 494 7 1 6 4.2 CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL207377 77074 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 494 7 1 6 4.2 CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
49863236 15232 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210754 15232 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 611 11 3 4 6.5 C=C(CNC1CCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
60141324 125945 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648505 125945 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 552 7 2 10 2.8 COc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
57383054 127215 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 587 10 2 7 4.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
CHEMBL3657644 127215 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 587 10 2 7 4.8 COc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
44411138 165833 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4cccnc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL424868 165833 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4cccnc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11433587 15223 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210745 15223 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 3 5 5.4 C=C(CN1CC[C@H](O)C1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
68867798 77533 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 11 0 6 2.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087429 77533 0 None - 1 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 11 0 6 2.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CCN(C)C)CC2)c(C)c1 10.1021/jm2016057
60142703 125917 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648477 125917 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 532 6 2 7 4.4 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60141182 125939 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
CHEMBL3648499 125939 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 567 7 2 9 3.8 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)COC2)on1 nan
44430694 87921 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 500 7 2 5 5.9 N#CC1(c2ccccc2OC(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL233887 87921 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 500 7 2 5 5.9 N#CC1(c2ccccc2OC(F)(F)F)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
44430692 87920 1 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 450 6 2 4 5.7 N#CC1(c2ccccc2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL233886 87920 1 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 450 6 2 4 5.7 N#CC1(c2ccccc2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
44430682 142077 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2cccc(F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL388030 142077 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2cccc(F)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
16220918 161470 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
CHEMBL412762 161470 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 585 9 2 6 4.7 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCOCC3)ccc21 10.1021/jm070055c
11227059 67363 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 584 8 2 7 3.8 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2cnnc2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL188617 67363 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assayBinding affinity to human Bradykinin receptor B1 over-expressed in transgenic rats was determined by ex vivo receptor occupancy assay
ChEMBL 584 8 2 7 3.8 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(-n2cnnc2)cc1 10.1016/j.bmcl.2004.09.074
44432223 167149 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 545 6 2 7 3.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
CHEMBL429074 167149 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 545 6 2 7 3.8 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ncc(-c2cc(Cl)cc(Cl)c2-c2nnn(C)n2)cc1F 10.1016/j.bmcl.2007.04.040
70687620 73850 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 624 7 1 5 5.5 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N1CCC(Cc2ccc(C3=NCCN3)cc2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018865 73850 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 624 7 1 5 5.5 O=C(CC1c2ccccc2CCN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N1CCC(Cc2ccc(C3=NCCN3)cc2)CC1 10.1016/j.bmcl.2012.03.065
11341448 77536 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 524 10 0 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087432 77536 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 524 10 0 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C(C)C)CC3)CC2)c(C)c1 10.1021/jm2016057
60142706 125920 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
CHEMBL3648480 125920 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 551 7 2 8 4.6 COc1cc(C(=O)NC2(C(=O)N[C@H]3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)on1 nan
44430687 88046 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2ccc(Cl)c(Cl)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234514 88046 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2ccc(Cl)c(Cl)c2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
49863237 15233 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210755 15233 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 625 11 3 4 6.9 C=C(CNC1CCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
11454567 77534 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 485 11 1 7 1.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(O)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087430 77534 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 485 11 1 7 1.1 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(C(O)CN(C)C)CC2)c(C)c1 10.1021/jm2016057
60142167 125897 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
CHEMBL3648458 125897 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 7 2.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)n1 nan
11284303 66342 0 None -2 2 Human 5.5 pKi = 5.5 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
CHEMBL185068 66342 0 None -2 2 Human 5.5 pKi = 5.5 Binding
Binding affinity for Bradykinin receptor B1 expressed in HEK293 cellsBinding affinity for Bradykinin receptor B1 expressed in HEK293 cells
ChEMBL 553 15 1 7 4.7 CN(C)CCCN(CCCN(C)C)S(=O)(=O)c1ccc(NC(c2ccccc2)c2ccccc2)c([N+](=O)[O-])c1 10.1021/jm049747g
16220913 85551 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227828 85551 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 515 8 3 5 4.3 NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
11467345 161951 0 None 489 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
CHEMBL415629 161951 0 None 489 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 581 9 2 4 6.4 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1021/jm061224g
57403175 69562 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934258 69562 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3c(Cl)cccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
44401834 124018 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 442 7 3 4 4.6 CNC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL362974 124018 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 442 7 3 4 4.6 CNC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
60142566 125909 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648469 125909 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 524 5 2 6 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)OCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
24895353 178953 3 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)c(F)c2)cc1 10.1021/jm800199h
CHEMBL470487 178953 3 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)c(F)c2)cc1 10.1021/jm800199h
11757682 122040 0 None -1949 4 Rat 7.5 pKi = 7.5 Binding
Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
CHEMBL359553 122040 0 None -1949 4 Rat 7.5 pKi = 7.5 Binding
Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1Binding affinity of the [35S]- radiolabeled compound to rat Bradykinin receptor B1
ChEMBL 567 8 3 6 3.5 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc2ccccc2c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2004.09.074
44411392 141256 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 524 6 1 7 4.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)OC)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL383089 141256 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 524 6 1 7 4.0 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C(=O)OC)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
49863227 15219 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210741 15219 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 627 10 2 4 6.9 CC(CN1CCCCC1)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
68869351 77523 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087419 77523 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
44569936 173185 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL452238 173185 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 627 14 1 6 5.9 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCCCC3)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
11495796 73535 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL201717 73535 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 436 7 2 4 3.6 COC(=O)c1ccccc1-c1ccc(CNC(=O)C(C)(C)NC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
44391980 65016 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.4 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCCC1 10.1016/j.bmcl.2005.05.133
CHEMBL182331 65016 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.4 COC(=O)C1=C(c2ccc(CNc3nccc(C)c3NC(=O)CC#N)cc2)CCCC1 10.1016/j.bmcl.2005.05.133
11442712 85226 0 None -89 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL225607 85226 0 None -89 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 466 7 2 6 5.4 COC(=O)c1c(F)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
11386138 84441 0 None -50 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
CHEMBL221998 84441 0 None -50 3 Rat 7.5 pKi = 7.5 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 482 7 2 6 5.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)Nc2nccc(Cl)c2NC(=O)CC#N)cc1 10.1021/jm049394l
44392010 65859 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 435 7 2 7 3.7 COC(=O)c1ccccc1N1CCC(C)(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL183538 65859 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 435 7 2 7 3.7 COC(=O)c1ccccc1N1CCC(C)(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
60142569 125914 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648474 125914 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 426 4 2 5 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(N)CC2)no1 nan
60142837 125926 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648486 125926 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 7 5.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
16220988 85535 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
CHEMBL227697 85535 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1C(F)(F)F)c1ccccc1 10.1021/jm070055c
25181410 172214 1 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
CHEMBL447392 172214 1 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 642 14 1 7 4.6 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN3CCN(C)CC3)cc2)ccc1OCC(C)C 10.1021/jm1000776
60142166 125896 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
CHEMBL3648457 125896 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 538 5 2 6 4.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)COC2)no1 nan
44392040 172880 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL451549 172880 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 444 7 2 6 4.3 COC(=O)C1C2C=CC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
60142165 125895 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
CHEMBL3648456 125895 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 496 5 2 5 3.3 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CC[C@@H]2NC(=O)C1(NC(=O)C(F)(F)F)COC1 nan
123884 2306 14 None -87 3 Human 6.4 pKi = 6.4 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
641 2306 14 None -87 3 Human 6.4 pKi = 6.4 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
CHEMBL80472 2306 14 None -87 3 Human 6.4 pKi = 6.4 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
16108967 84344 0 None 147 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
CHEMBL221691 84344 0 None 147 2 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D cells
ChEMBL 541 10 2 4 5.6 O=C(CC(NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)NCc1ccc(CN2CCCCC2)cc1 10.1021/jm061224g
44391962 64735 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.4 COC(=O)c1ccccc1C1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
CHEMBL181899 64735 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 420 7 2 6 4.4 COC(=O)c1ccccc1C1CCC(CNc2nccc(C)c2NC(=O)CC#N)CC1 10.1016/j.bmcl.2005.05.133
10001334 70125 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 405 8 2 6 3.7 COCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL194018 70125 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 405 8 2 6 3.7 COCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
16220986 137617 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
CHEMBL375709 137617 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 555 9 3 5 5.3 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccccc1Cl)c1ccccc1 10.1021/jm070055c
57403174 69560 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934256 69560 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 510 5 1 4 6.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(F)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
60142963 125929 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125929 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
60143095 125930 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648490 125930 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)cnc43)CC2)cn1 nan
56835162 69564 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934260 69564 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cccc(Cl)c3c2=O)cc1 10.1016/j.bmcl.2011.10.068
44411343 77264 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 9 1 6 4.8 C=CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208006 77264 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 520 9 1 6 4.8 C=CCCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
60142704 125918 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648478 125918 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 521 6 2 7 4.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
11635365 174561 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
CHEMBL455642 174561 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(C(F)(F)F)c1 10.1016/j.bmcl.2008.07.108
57342496 77516 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(Cl)cccc1Cl 10.1021/jm2016057
CHEMBL2087412 77516 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 512 10 1 6 2.6 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1c(Cl)cccc1Cl 10.1021/jm2016057
57382921 124419 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 8 2.5 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
CHEMBL3639564 124419 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 545 6 2 8 2.5 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)COC1)c1ncc(-c2cc(Cl)cc(F)c2-c2nnn(C)n2)cc1F nan
57383055 127216 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
CHEMBL3657645 127216 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ccc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
70693873 73848 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.4 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018863 73848 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 576 8 2 5 5.4 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@H](CCC2=NCCN2)CC1 10.1016/j.bmcl.2012.03.065
57342849 77517 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 11 1 7 2.0 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(Cl)c1 10.1021/jm2016057
CHEMBL2087413 77517 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 11 1 7 2.0 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(Cl)c1 10.1021/jm2016057
60142303 125902 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648462 125902 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 6 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60141466 125950 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
CHEMBL3648510 125950 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 569 7 2 10 3.6 COc1cc(C(=O)NC2(C(=O)NC3CSc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)ccc43)CC2)on1 nan
16047262 77208 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207937 77208 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
60141185 125942 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
CHEMBL3648502 125942 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 563 7 2 10 2.6 COc1ncc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)cn1 nan
11260745 77528 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CC3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087424 77528 0 None - 1 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CC3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
46911684 15231 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210753 15231 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 599 11 3 4 6.3 C=C(CNC(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
57382797 127189 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 9 2 7 4.2 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
CHEMBL3657618 127189 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 558 9 2 7 4.2 C[C@@H](NC(=O)C1(NC(=O)c2ccno2)COC1)c1ncc(-c2cc(Cl)cc(Cl)c2OCC(F)F)cc1F nan
23627458 73854 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018869 73854 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 564 8 2 5 5.0 Cc1ccc(S(=O)(=O)N2c3ccccc3-c3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.bmcl.2012.03.065
16221228 166017 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL425490 166017 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 593 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
68870388 77539 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CN3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087435 77539 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 10 0 7 1.4 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(CN3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
60141041 125936 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
CHEMBL3648496 125936 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 548 6 2 8 3.6 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3cncnc3)COC2)no1 nan
60141464 125948 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
CHEMBL3648508 125948 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 550 6 2 9 3.4 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3cncnc3)CC2)n1 nan
16221055 142748 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389249 142748 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
44430688 88159 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2cccc(Cl)c2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234720 88159 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 484 6 2 4 6.3 N#CC1(c2cccc(Cl)c2Cl)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
10456579 124617 0 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 453 8 2 7 3.1 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CS(C)(=O)=O)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL364073 124617 0 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 453 8 2 7 3.1 COC(=O)c1ccccc1-c1ccc(CNc2ncccc2NC(=O)CS(C)(=O)=O)cc1 10.1016/j.bmcl.2005.02.077
16221226 144398 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
CHEMBL390603 144398 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 3 5 5.6 Cc1c(Cl)cccc1S(=O)(=O)N[C@H](CC(=O)N[C@@H]1CCOc2cc(CNC(C)(C)C)ccc21)c1ccccc1 10.1021/jm070055c
11663606 194579 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL530554 194579 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 2 5 4.5 O=C(C[C@H](O)CS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
11466010 84414 0 None -6 3 Rabbit 7.4 pKi = 7.4 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
CHEMBL221984 84414 0 None -6 3 Rabbit 7.4 pKi = 7.4 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
60142302 125901 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648461 125901 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
44569940 178731 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 11 2 5 3.1 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
CHEMBL468493 178731 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 514 11 2 5 3.1 O=C(O)CCNC(=O)CN(CCOc1ccc2c(c1)CCC2)S(=O)(=O)c1ccc(Cl)cc1Cl 10.1016/j.bmcl.2008.11.005
57401426 69566 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934262 69566 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3cc(Cl)ccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
49863233 15228 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210750 15228 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 615 13 3 5 5.6 C=C(CNCCOC)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
57399670 69557 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1934253 69557 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2ccc(C(=O)N[C@H]3CCCc4cc(CN5CCCCC5)ccc43)cc2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
24895449 186717 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)nc2)cc1 10.1021/jm800199h
CHEMBL488626 186717 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 413 6 2 5 3.2 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)nc2)cc1 10.1021/jm800199h
11620980 173712 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
CHEMBL453596 173712 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1C(F)(F)F 10.1016/j.bmcl.2008.07.108
24895355 186699 3 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccncc2)cc1 10.1021/jm800199h
CHEMBL488461 186699 3 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccncc2)cc1 10.1021/jm800199h
4227718 179046 7 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL471371 179046 7 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
4227718 179046 7 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
CHEMBL471371 179046 7 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 394 6 2 4 3.7 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm1000776
60142833 125922 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648482 125922 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 444 4 2 5 4.2 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
11641218 73232 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 462 7 2 4 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCC2)cc1 10.1021/jm0511280
CHEMBL201210 73232 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 462 7 2 4 4.1 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCC2)cc1 10.1021/jm0511280
60142707 125921 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648481 125921 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 544 5 2 6 5.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cc(F)c3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
11596635 86816 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 407 6 3 4 4.5 O=C(CC(F)(F)F)Nc1cccnc1NCC1CCC(O)(c2ccccc2)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL232237 86816 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 407 6 3 4 4.5 O=C(CC(F)(F)F)Nc1cccnc1NCC1CCC(O)(c2ccccc2)CC1 10.1016/j.bmcl.2007.03.059
44455147 98055 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL273156 98055 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 403 5 2 4 3.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
11635364 174562 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
CHEMBL455643 174562 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 554 8 3 6 3.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2008.07.108
70689675 73843 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 572 8 2 6 4.0 O=C(CC1COc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018858 73843 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 572 8 2 6 4.0 O=C(CC1COc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
57392728 69567 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
CHEMBL1934263 69567 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@H]1CCCc2cc(CN3CCCCC3)ccc21)c1ccc(-c2coc3c(Cl)cccc3c2=O)cc1 10.1016/j.bmcl.2011.10.068
70685470 73845 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.2 O=C(CC1Cc2ccccc2CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018860 73845 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.2 O=C(CC1Cc2ccccc2CN1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
44430685 88045 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 474 7 2 6 4.8 COC(=O)c1cccc(C2(C#N)CCC(CNc3ncccc3NC(=O)CC(F)(F)F)CC2)c1 10.1016/j.bmcl.2007.03.059
CHEMBL234513 88045 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 474 7 2 6 4.8 COC(=O)c1cccc(C2(C#N)CCC(CNc3ncccc3NC(=O)CC(F)(F)F)CC2)c1 10.1016/j.bmcl.2007.03.059
16221111 85539 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227721 85539 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
16221109 144047 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL390311 144047 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 9 3 5 6.1 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
88574478 127188 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
CHEMBL3657617 127188 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 572 9 2 7 4.5 Cc1cc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)on1 nan
57382880 127198 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 559 7 2 10 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nnc(C)o4)COC3)c(F)c2)no1 nan
CHEMBL3657627 127198 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 559 7 2 10 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nnc(C)o4)COC3)c(F)c2)no1 nan
11620871 166035 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL425588 166035 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptor Q295 mutantBinding affinity to human BK1 receptor Q295 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccncc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411068 140912 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 512 8 1 6 4.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCF)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL382228 140912 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 512 8 1 6 4.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCF)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
57382795 127187 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 516 7 2 5 3.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)COC2)c(F)c1 nan
CHEMBL3657616 127187 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 516 7 2 5 3.9 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)CC(F)(F)F)COC2)c(F)c1 nan
60141038 125934 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
CHEMBL3648494 125934 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 564 7 2 9 3.8 COc1ncc(C(=O)NC2(C(=O)NC3COc4cc(-c5cc(Cl)cc(F)c5-c5noc(C)n5)ccc43)CC2)cn1 nan
16220916 85561 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227879 85561 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 571 9 3 5 5.8 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44411393 77007 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 466 6 2 6 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCNCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207122 77007 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 466 6 2 6 3.5 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCNCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16221108 85531 0 None 27 2 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL227600 85531 0 None 27 2 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 605 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
57342847 77514 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 488 11 1 7 1.6 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
CHEMBL2087410 77514 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 488 11 1 7 1.6 COc1ccc(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm2016057
44316621 82116 0 None 57 2 Human 8.3 pKi = 8.3 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1091 24 13 15 -4.9 NC(N)=NCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
CHEMBL216618 82116 0 None 57 2 Human 8.3 pKi = 8.3 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL 1091 24 13 15 -4.9 NC(N)=NCCCC(N)C(=O)N[C@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CC(O)C[C@H]1C(=O)NCC(=O)NC(C(=O)N[C@@H](CO)C(=O)N[C@@H]1CSc2ccccc2N(CC(=O)O)C1=O)C1Cc2ccccc2C1 10.1021/jm990961s
24895255 185376 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 556 10 3 5 5.0 O=C(NCCCN1CCCC(F)(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
CHEMBL486052 185376 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 556 10 3 5 5.0 O=C(NCCCN1CCCC(F)(F)C1)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccccc2)cc1 10.1021/jm800199h
9852117 77522 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087418 77522 0 None - 1 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 508 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN([C@@H]3CN4CCC3CC4)CC2)c(C)c1 10.1021/jm2016057
16221161 144321 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
CHEMBL390539 144321 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 569 9 2 5 5.5 O=C(C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1)N[C@@H]1CCOc2cc(CN3CCCC3)ccc21 10.1021/jm070055c
11071992 60325 0 None 3 2 Human 8.2 pKi = 8.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL1744082 60325 0 None 3 2 Human 8.2 pKi = 8.2 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 584 7 2 5 6.4 CCCN1C(=O)[C@H](NC(=O)Nc2ccc(N3CCC(N4CCCCC4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
71229238 125943 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648503 125943 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 9 2.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
68868627 77531 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 484 12 0 7 1.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCCN(C)C)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087427 77531 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 484 12 0 7 1.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(CCCN(C)C)CC2)c(C)c1 10.1021/jm2016057
60142438 125907 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648467 125907 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 5 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
16221057 143020 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL389478 143020 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 607 11 3 5 5.6 CC(C)CNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccc(F)cc1 10.1021/jm070055c
3102216 188167 6 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 493 6 2 5 4.2 COc1ccccc1NC(=O)CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1c(C)cc(C)cc1C 10.1016/j.bmcl.2008.07.055
CHEMBL498679 188167 6 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 493 6 2 5 4.2 COc1ccccc1NC(=O)CC1C(=O)Nc2ccccc2N1S(=O)(=O)c1c(C)cc(C)cc1C 10.1016/j.bmcl.2008.07.055
57382963 127204 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nccn4C)COC3)c(F)c2)no1 nan
CHEMBL3657633 127204 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4nccn4C)COC3)c(F)c2)no1 nan
44455255 95435 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 335 5 2 4 2.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CO)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL257053 95435 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 335 5 2 4 2.0 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)CO)c(F)c1 10.1016/j.bmcl.2007.11.050
44411153 141230 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL382909 141230 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 548 7 1 6 4.7 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CC(F)(F)F)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11553268 74395 0 None - 1 Human 4.3 pKi = 4.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 408 7 2 4 2.8 COC(=O)c1ccccc1-c1ccc(CNC(=O)CNC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
CHEMBL202463 74395 0 None - 1 Human 4.3 pKi = 4.3 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 408 7 2 4 2.8 COC(=O)c1ccccc1-c1ccc(CNC(=O)CNC(=O)CC(F)(F)F)cc1 10.1021/jm0511280
60142169 125900 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
CHEMBL3648460 125900 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 494 5 2 4 4.5 COC(=O)c1c(Cl)cccc1-c1ccc2c(c1)CCCC2NC(=O)C1(NC(=O)C(F)(F)F)CC1 nan
44392133 66095 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 446 7 2 6 4.5 COC(=O)C1C2CCC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL183876 66095 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 446 7 2 6 4.5 COC(=O)C1C2CCC(CC2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11555433 188989 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
CHEMBL508632 188989 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 520 8 3 6 3.0 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1cccc(Cl)c1 10.1016/j.bmcl.2008.07.108
10282203 188417 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 600 9 2 5 6.8 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
CHEMBL50208 188417 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 600 9 2 5 6.8 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCC(c4ccncc4)CC3)cc2)N=C(CCc2ccccc2)c2ccccc21 10.1021/jm034020y
24895181 178952 3 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2F)cc1 10.1021/jm800199h
CHEMBL470486 178952 3 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 430 6 2 4 4.0 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(F)cc2F)cc1 10.1021/jm800199h
11605512 173603 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
CHEMBL453340 173603 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 486 8 3 6 2.4 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)[C@H](O)[C@H](O)CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2008.07.108
44587207 188148 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
CHEMBL498489 188148 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 573 6 2 6 4.4 O=Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2008.07.055
44455074 155532 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL404246 155532 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 417 5 2 4 3.3 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@](C)(O)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
70688995 77452 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 611 14 5 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN)C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
CHEMBL2087029 77452 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to B1 receptorBinding affinity to B1 receptor
ChEMBL 611 14 5 6 2.9 Cc1c(Cl)ccc(S(=O)(=O)N[C@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN)C(=O)NCC2CCNCC2)c1Cl 10.1021/jm2016057
44455256 167074 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 361 5 2 4 2.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(O)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL428954 167074 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 361 5 2 4 2.6 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C2(O)CC2)c(F)c1 10.1016/j.bmcl.2007.11.050
11691896 186705 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
CHEMBL488512 186705 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 504 8 1 4 5.6 O=C(CCCS(=O)(=O)c1ccc2ccccc2c1)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21 10.1016/j.bmcl.2008.07.108
60142961 125927 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
CHEMBL3648487 125927 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 427 4 2 6 3.5 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(N)CC2)no1 nan
11466010 84414 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
CHEMBL221984 84414 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10, leu9-kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 8 4.8 C[C@@H](Nc1nccc(Cl)c1NC(=O)CC#N)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1 10.1021/jm049394l
44402298 71636 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 470 7 3 4 5.5 CNC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL196352 71636 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 470 7 3 4 5.5 CNC(=O)c1ccccc1-c1ccc([C@@H](C)Nc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
60142028 125894 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648455 125894 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 5 2 5 4.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60143096 125931 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
CHEMBL3648491 125931 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 522 6 2 8 4.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccno3)CC2)no1 nan
60141323 125944 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
CHEMBL3648504 125944 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 9 3.1 Cc1cc(C(=O)NC2(C(=O)NC3CCc4cc(-c5cc(Cl)cc(F)c5-c5nnn(C)n5)cnc43)CC2)on1 nan
70691812 73844 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.6 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018859 73844 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 570 8 2 5 4.6 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
11526655 186567 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
CHEMBL487823 186567 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in clone CHO-D-/aequorin cells
ChEMBL 534 9 1 5 5.2 CO[C@@H](CC(=O)N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)CS(=O)(=O)c1ccc2ccccc2c1 10.1016/j.bmcl.2008.07.108
57382793 127185 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 502 6 2 5 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)COC2)c(F)c1 nan
CHEMBL3657614 127185 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 502 6 2 5 3.6 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)COC2)c(F)c1 nan
11953367 17071 19 None -19 2 Mouse 8.2 pKi = 8.2 Binding
Binding affinity to mouse bradykinin B1 receptorBinding affinity to mouse bradykinin B1 receptor
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
CHEMBL1254771 17071 19 None -19 2 Mouse 8.2 pKi = 8.2 Binding
Binding affinity to mouse bradykinin B1 receptorBinding affinity to mouse bradykinin B1 receptor
ChEMBL 502 11 1 7 2.0 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c(C)c1 10.1021/jm1000776
60142567 125912 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648472 125912 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 7 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142440 125908 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648468 125908 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 5 2 6 3.8 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CCC3(C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
16221283 85532 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
CHEMBL227655 85532 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 609 12 3 6 4.9 COCCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccc(F)cc1 10.1021/jm070055c
57342852 77519 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 492 10 1 6 2.3 Cc1c(Cl)cccc1S(=O)(=O)N(C)CCOCC(=O)N(C)Cc1ccc(C2=NCCN2)cc1 10.1021/jm2016057
CHEMBL2087415 77519 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 492 10 1 6 2.3 Cc1c(Cl)cccc1S(=O)(=O)N(C)CCOCC(=O)N(C)Cc1ccc(C2=NCCN2)cc1 10.1021/jm2016057
44430683 87999 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccc(F)cc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
CHEMBL234297 87999 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at human bradykinin B1 receptorBinding affinity at human bradykinin B1 receptor
ChEMBL 434 6 2 4 5.2 N#CC1(c2ccc(F)cc2)CCC(CNc2ncccc2NC(=O)CC(F)(F)F)CC1 10.1016/j.bmcl.2007.03.059
54585539 62200 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
CHEMBL1777973 62200 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation countingDisplacement of [3H]-DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells membrane after 90 mins by scintillation counting
ChEMBL 470 6 3 5 1.5 Cc1ccc(S(=O)(=O)N2CCNC(=O)[C@H]2CC(=O)N[C@@H]2CCCc3cc(CN)ccc32)cc1 10.1016/j.bmcl.2011.11.112
44411338 138430 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 7 1 5 5.9 COC(=O)c1c(Cl)cccc1-c1ccc(CNc2cc(CN3CCCCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL377440 138430 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 7 1 5 5.9 COC(=O)c1c(Cl)cccc1-c1ccc(CNc2cc(CN3CCCCC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411245 77295 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 542 7 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208210 77295 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 542 7 1 6 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccc4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
16102922 84234 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1F 10.1021/jm061094b
CHEMBL220978 84234 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-Arg10 Leu9 kallidin from human bradykinin B1 receptor expressed in CHO cells
ChEMBL 494 6 2 6 3.2 C[C@@H](NC(=O)C1(NC(=O)C(F)(F)F)CC1)c1ccc(-c2cccc(F)c2-c2nnnn2C)cc1F 10.1021/jm061094b
70691813 73420 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 7.0 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2016601 73420 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 640 7 1 5 7.0 O=C(CC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)Nc1ccc(N2CCC(N3CCCCC3)CC2)cc1 10.1016/j.bmcl.2012.03.065
11546560 73936 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm0511280
CHEMBL202089 73936 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 434 7 2 4 3.4 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CC2)cc1 10.1021/jm0511280
60141183 125940 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
CHEMBL3648500 125940 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 527 5 2 8 3.9 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)n1 nan
12085225 77518 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 10 1 7 1.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C#N 10.1021/jm2016057
CHEMBL2087414 77518 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 469 10 1 7 1.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccccc1C#N 10.1021/jm2016057
56594373 65883 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
CHEMBL1835762 65883 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 506 5 1 5 5.5 Cc1nn(-c2cccc(C(=O)N[C@@H]3CCCc4cc(CN5CCCCC5)ccc43)c2)c(=O)c2ccccc12 10.1016/j.bmcl.2011.10.068
56594241 65877 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1835756 65877 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 492 5 1 4 6.3 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccccc3c2=O)c1 10.1016/j.bmcl.2011.10.068
44411252 76890 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76890 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895112 176721 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2)cc1 10.1021/jm800199h
CHEMBL460046 176721 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 412 6 2 4 3.8 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccc(F)c2)cc1 10.1021/jm800199h
12085129 77455 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 9 1 5 3.7 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087033 77455 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 510 9 1 5 3.7 Cc1c(Cl)ccc(S(=O)(=O)N(C)CCCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
44455181 97440 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL270017 97440 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 349 5 2 4 2.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@H](C)O)c(F)c1 10.1016/j.bmcl.2007.11.050
60142568 125913 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
CHEMBL3648473 125913 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 526 5 2 6 5.7 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)OC(C)(C)C)CC2)no1 nan
24970501 188132 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 516 8 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCc3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.ejmech.2007.10.030
CHEMBL498394 188132 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation countingDisplacement of [3H]Lys-bradykinin from human recombinant bradykinin B1 receptor expressed in CHO cells by scintillation counting
ChEMBL 516 8 2 5 3.4 Cc1ccc(S(=O)(=O)N2CCc3ccccc3C2CC(=O)NCCc2ccc(C3=NCCN3)cc2)cc1 10.1016/j.ejmech.2007.10.030
11281533 65077 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL182378 65077 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 418 7 2 6 4.1 COC(=O)C1CC=CCC1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
60141465 125949 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
CHEMBL3648509 125949 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 539 6 2 9 3.6 Cn1nnc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)c3ccno3)CC2)n1 nan
57383096 127219 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 589 9 2 8 4.4 Cc1nnsc1C(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
CHEMBL3657648 127219 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 589 9 2 8 4.4 Cc1nnsc1C(=O)NC1(C(=O)N[C@H](C)c2ncc(-c3cc(Cl)cc(Cl)c3OCC(F)F)cc2F)COC1 nan
71456247 79007 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 457 7 2 5 5.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL2113085 79007 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 457 7 2 5 5.3 COC(=O)c1ccccc1-c1ccc(CNc2nccc(C)c2NC(=O)CC(F)(F)F)cc1 10.1016/j.bmcl.2005.02.077
16102897 87239 17 None -7 3 Rabbit 8.1 pKi = 8.1 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
CHEMBL232943 87239 17 None -7 3 Rabbit 8.1 pKi = 8.1 Binding
Binding affinity to rabbit bradykinin B1 receptorBinding affinity to rabbit bradykinin B1 receptor
ChEMBL 486 6 2 4 4.3 COC(=O)c1c(Cl)cccc1-c1ccc([C@@H](C)NC(=O)C2(NC(=O)C(F)(F)F)CC2)c(F)c1 10.1021/jm061094b
60142963 125929 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
CHEMBL3648489 125929 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 533 6 2 8 3.8 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)c3ccnnc3)CC2)no1 nan
44432178 87397 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1noc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1016/j.bmcl.2007.04.040
CHEMBL233350 87397 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 510 6 2 5 4.9 Cc1noc(-c2ccc(Cl)cc2-c2ccc([C@@H](C)NC(=O)C3(NC(=O)C(F)(F)F)CC3)c(F)c2)n1 10.1016/j.bmcl.2007.04.040
16220990 85546 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
CHEMBL227786 85546 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.9 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/jm070055c
659 2898 17 None 1 2 Rhesus macaque 8.1 pKi = 8.1 Binding
Binding affinity to monkey bradykinin B1 receptorBinding affinity to monkey bradykinin B1 receptor
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
9831083 2898 17 None 1 2 Rhesus macaque 8.1 pKi = 8.1 Binding
Binding affinity to monkey bradykinin B1 receptorBinding affinity to monkey bradykinin B1 receptor
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
CHEMBL273869 2898 17 None 1 2 Rhesus macaque 8.1 pKi = 8.1 Binding
Binding affinity to monkey bradykinin B1 receptorBinding affinity to monkey bradykinin B1 receptor
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
44411091 77102 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 465 6 1 5 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207539 77102 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 465 6 1 5 5.1 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
24895352 179184 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(Cl)cc2)cc1 10.1021/jm800199h
CHEMBL472303 179184 3 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 428 6 2 4 4.3 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2ccc(Cl)cc2)cc1 10.1021/jm800199h
44455148 97419 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 377 6 2 4 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL269948 97419 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 377 6 2 4 3.1 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
24895183 188295 3 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccnc2)cc1 10.1021/jm800199h
CHEMBL500312 188295 3 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 395 6 2 5 3.1 CC(=O)Nc1ccc(S(=O)(=O)Nc2ccccc2C(=O)c2cccnc2)cc1 10.1021/jm800199h
44411252 76890 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76890 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptor N298 mutantBinding affinity to human BK1 receptor N298 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11375297 92572 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
CHEMBL243467 92572 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cellsDisplacement of [3H]DAKA from human bradykinin B1 receptor in IL1-beta stimulated IMR90 cells
ChEMBL 490 6 3 5 3.7 COC(=O)[C@@H](NC(=O)c1n[nH]c(NC(=O)c2ccccc2Cl)c1Br)c1ccccc1 10.1021/jm051292n
44392113 65866 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 432 7 2 6 4.2 COC(=O)C1C2CCC(C2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
CHEMBL183562 65866 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity against Human bradykinin receptor B1Binding affinity against Human bradykinin receptor B1
ChEMBL 432 7 2 6 4.2 COC(=O)C1C2CCC(C2)C1c1ccc(CNc2nccc(C)c2NC(=O)CC#N)cc1 10.1016/j.bmcl.2005.05.133
11670114 73089 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 7 2 4 4.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCCC2)cc1 10.1021/jm0511280
CHEMBL201107 73089 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 476 7 2 4 4.5 COC(=O)c1ccccc1-c1ccc(CNC(=O)C2(NC(=O)CC(F)(F)F)CCCCC2)cc1 10.1021/jm0511280
57390933 69559 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
CHEMBL1934255 69559 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human B1 bradykinin receptorBinding affinity to human B1 bradykinin receptor
ChEMBL 526 5 1 4 6.9 O=C(N[C@@H]1CCCc2cc(CN3CCCCC3)ccc21)c1cccc(-c2coc3ccc(Cl)cc3c2=O)c1 10.1016/j.bmcl.2011.10.068
16220989 142499 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
CHEMBL389054 142499 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 589 9 3 5 5.6 CC(C)(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1 10.1021/jm070055c
49863231 15226 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
CHEMBL1210748 15226 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptorDisplacement of [3H]Lys-desArg9-BK from human bradykinin B1 receptor
ChEMBL 585 10 2 4 5.9 C=C(CN(C)C)c1ccc2c(c1)CCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1016/j.bmcl.2010.06.010
10187167 77540 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 539 9 2 6 2.0 Cc1c(Cl)ccc(S(=O)(=O)N(C)CC(=O)NCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
CHEMBL2087436 77540 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 539 9 2 6 2.0 Cc1c(Cl)ccc(S(=O)(=O)N(C)CC(=O)NCC(=O)N(C)Cc2ccc(C3=NCCN3)cc2)c1Cl 10.1021/jm2016057
44411372 77301 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 506 8 1 6 4.4 C=CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
CHEMBL208241 77301 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 506 8 1 6 4.4 C=CCN1CCN(C(=O)c2ccc(NCc3ccc(-c4cccc(F)c4C(=O)OC)cc3F)nc2)CC1 10.1016/j.bmcl.2006.01.112
659 2898 17 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
9831083 2898 17 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
CHEMBL273869 2898 17 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cellsDisplacement of [3H]Lys0-des-Arg9-BK at human bradykinin B1 receptor expressed in HEK293 cells
ChEMBL 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 10.1021/jm1000776
16220915 85534 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL227690 85534 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 557 10 3 5 5.4 CC(C)NCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
57383056 127217 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 9 2 8 3.9 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
CHEMBL3657646 127217 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 573 9 2 8 3.9 Cc1nnc(C(=O)NC2(C(=O)N[C@H](C)c3ncc(-c4cc(Cl)cc(Cl)c4OCC(F)F)cc3F)COC2)o1 nan
23627583 73859 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
CHEMBL2018874 73859 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 655 9 1 5 7.5 COc1cccc2c1-c1ccccc1N(S(=O)(=O)c1ccc(Cl)c(Cl)c1)C2CC(=O)N[C@H]1CC[C@H](CCN2CCCC2)CC1 10.1016/j.bmcl.2012.03.065
16221110 85035 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL224071 85035 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 10 3 5 5.0 CCNCc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44411092 77036 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207178 77036 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 467 6 1 6 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCOCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11363856 84535 0 None -162 3 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
CHEMBL222038 84535 0 None -162 3 Rat 7.1 pKi = 7.1 Binding
Displacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cellsDisplacement of [3H]des-arg10 kallidin from rat bradykinin B1 receptor expressed in CHO cells
ChEMBL 490 7 2 7 5.9 Cc1noc(-c2c(F)cccc2-c2ccc([C@@H](C)Nc3nccc(Cl)c3NC(=O)CC#N)cc2)n1 10.1021/jm049394l
44411297 77361 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208538 77361 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 354 5 1 4 4.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
57382964 127205 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cn(C)cn4)COC3)c(F)c2)no1 nan
CHEMBL3657634 127205 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.Binding Assay: For binding, Bradykinin-1 receptor antagonist compounds were added in various concentrations in 50 mM Tris pH 7.4, 5 mM MgCl2 together with 6 nM Kallidin (Des Arg10, Leu9), [3,4-Prolyl-3,4-3H(N)] (PerkinElmer, 1.85-4.44 TBq/mmol) to 40 μg membrane protein containing approximately 1 fmol Bradykinin-1 receptor and incubated for 15 min at 27° C. To determine non-specific binding 10 μM Lys-(Des-Arg9)-Bradykinin (Bachem) was added. Membranes were harvested through GF/B (glass fiber filter; PerkinElmer) plates, equilibrated with 0.5% polyethylenimine, air dried at 50° C. for 2 hr. Radioactivity was determined by counting in a topcounter (NXT Packard). Specific binding was defined as total binding minus nonspecific binding and typically represents about 90-95% of the total binding. Antagonist activity is expressed as Ki: inhibitor concentration required for 50% inhibition of specific binding corrected for the concentration of the radioligand.
ChEMBL 557 7 2 9 3.1 Cc1nc(-c2c(F)cc(Cl)cc2-c2cnc([C@@H](C)NC(=O)C3(NC(=O)c4cn(C)cn4)COC3)c(F)c2)no1 nan
44316620 2121 0 None -19 2 Human 7.1 pKi = 7.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
656 2121 0 None -19 2 Human 7.1 pKi = 7.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
CHEMBL408846 2121 0 None -19 2 Human 7.1 pKi = 7.1 Binding
Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.Ability to bind to human cloned B1 receptor in competition binding experiments with [3H][des-Arg10,Leu9]-Kallidin.
ChEMBL None None None None 10.1021/jm990961s
44455107 97994 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 6 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL272791 97994 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 6 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@](C)(O)C(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
16220917 166335 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
CHEMBL427279 166335 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cellsDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHOD cells
ChEMBL 543 9 2 5 5.0 CN(C)Cc1ccc2c(c1)OCC[C@H]2NC(=O)C[C@@H](NS(=O)(=O)c1ccc2ccccc2c1)c1ccccc1 10.1021/jm070055c
44411252 76890 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207011 76890 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human BK1 receptor D291 mutantBinding affinity to human BK1 receptor D291 mutant
ChEMBL 543 7 1 7 4.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(c4ccccn4)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
12085227 77521 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 528 11 1 7 2.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccc(OC(F)(F)F)cc1 10.1021/jm2016057
CHEMBL2087417 77521 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 528 11 1 7 2.2 CN(Cc1ccc(C2=NCCN2)cc1)C(=O)COCCN(C)S(=O)(=O)c1ccc(OC(F)(F)F)cc1 10.1021/jm2016057
10281725 979 0 None -7 2 Human 7.1 pKi = 7.1 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 10.1021/jm034020y
666 979 0 None -7 2 Human 7.1 pKi = 7.1 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 10.1021/jm034020y
CHEMBL299164 979 0 None -7 2 Human 7.1 pKi = 7.1 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 10.1021/jm034020y
44587206 188147 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
CHEMBL498488 188147 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration techniqueDisplacement of [3H]DAK from human bradykinin B1 receptor expressed in CHO-D-/aequorin cells by rapid filtration technique
ChEMBL 575 6 3 6 4.0 O=C(C[C@@H]1C(=O)Nc2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)N[C@@H]1CCOc2cc(CO)ccc21 10.1016/j.bmcl.2008.07.055
44402279 71178 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 8 2 5 4.9 CCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
CHEMBL195617 71178 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cellsInhibitory constant against human Bradykinin receptor B1 expressed in chinese hamster ovary cells
ChEMBL 403 8 2 5 4.9 CCCC(=O)Nc1cccnc1NCc1ccc(-c2ccccc2C(=O)OC)cc1 10.1016/j.bmcl.2005.02.077
44455145 97912 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 5 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL272491 97912 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 391 5 2 4 3.4 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)[C@@H](O)C(C)(C)C)c(F)c1 10.1016/j.bmcl.2007.11.050
44411134 77302 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCN(C)CC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208247 77302 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 480 6 1 6 3.8 COC(=O)c1c(F)cccc1-c1ccc(CNc2cc(C(=O)N3CCN(C)CC3)ccn2)c(F)c1 10.1016/j.bmcl.2006.01.112
44411135 77303 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 451 7 1 5 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL208248 77303 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 451 7 1 5 5.4 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(CN3CCCCC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
23627523 73857 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
CHEMBL2018872 73857 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human bradykinin B1 receptorBinding affinity to human bradykinin B1 receptor
ChEMBL 654 8 2 5 6.3 O=C(CC1c2cc(F)cc(F)c2-c2ccccc2N1S(=O)(=O)c1ccc(Cl)c(Cl)c1)NCCc1ccc(C2=NCCN2)cc1 10.1016/j.bmcl.2012.03.065
60142304 125903 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
CHEMBL3648463 125903 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 523 5 2 7 3.0 Cn1nnc(-c2c(F)cc(Cl)cc2-c2cnc3c(c2)CCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)n1 nan
60142441 125911 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
CHEMBL3648471 125911 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 540 5 2 6 5.0 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)SCC3NC(=O)C2(NC(=O)C(F)(F)F)CC2)no1 nan
60142705 125919 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
CHEMBL3648479 125919 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding Assay: Binding assay using Bradykinin-1 receptor.Binding Assay: Binding assay using Bradykinin-1 receptor.
ChEMBL 536 6 2 8 4.3 Cc1nc(-c2c(F)cc(Cl)cc2-c2ccc3c(c2)CC[C@@H]3NC(=O)C2(NC(=O)c3nnc(C)o3)CC2)no1 nan
44411058 77197 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 536 9 1 6 5.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
CHEMBL207913 77197 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human BK1 receptorBinding affinity to human BK1 receptor
ChEMBL 536 9 1 6 5.2 COC(=O)c1c(F)cccc1-c1ccc(CNc2ccc(C(=O)N3CCN(CCC(C)C)CC3)cn2)c(F)c1 10.1016/j.bmcl.2006.01.112
11752335 77535 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
CHEMBL2087431 77535 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counterDisplacement of [3H]des-Arg10-KD from human recombinant B1 receptor expressed in HEK293 cells by liquid scintillation counter
ChEMBL 496 9 0 7 1.2 COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCC(N3CCN(C)CC3)CC2)c(C)c1 10.1021/jm2016057
25181411 189293 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
CHEMBL512111 189293 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of [3H]desArg from human B1 in human WI 38 cellsDisplacement of [3H]desArg from human B1 in human WI 38 cells
ChEMBL 587 14 1 6 5.0 COc1cc(CN(CC(=O)NCc2ccccc2Cl)S(=O)(=O)c2ccc(CN(C)C)cc2)ccc1OCC(C)C 10.1016/j.bmcl.2008.11.005
44455228 95423 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 471 5 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(O)(C(F)(F)F)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
CHEMBL257016 95423 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human bradykinin B1 receptor expressed in CHO cellsBinding affinity to human bradykinin B1 receptor expressed in CHO cells
ChEMBL 471 5 2 4 3.9 COC(=O)c1c(F)cccc1-c1ccc(CNC(=O)C(O)(C(F)(F)F)C(F)(F)F)c(F)c1 10.1016/j.bmcl.2007.11.050
10120979 101614 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccccn4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
CHEMBL298860 101614 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of human bradykinin B1 receptorInhibition of human bradykinin B1 receptor
ChEMBL 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(N3CCN(c4ccccn4)CC3)cc2)N=C(C2CCCCC2)c2ccccc21 10.1021/jm034020y
122227 1378 31 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
3825 1378 31 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
644 1378 31 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
CHEMBL264100 1378 31 None 6 3 Human 9.4 pKd None 9.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None None
119376 1841 48 3H-BRADYKININ -43651 26 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
247 1841 48 3H-BRADYKININ -43651 26 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
CHEMBL33884 1841 48 3H-BRADYKININ -43651 26 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 393 7 1 6 1.6 O=C(c1cn(c2c1cccc2)C)OCC1CCN(CC1)CCNS(=O)(=O)C None
44208932 140707 7 UNDEFINED -89125 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
CHEMBL381689 140707 7 UNDEFINED -89125 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
None 216128 0 3H-BRADYKININ -1 13 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 164 3 1 3 0.8 C1CNC1COC2=CN=CC=C2 None
122173054 217734 0 None 1 6 Rat 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 1304 30 18 17 -4.4 N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@H]3CCCC[C@H]3C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2 None
122173054 217734 0 None -1 6 Human 8.2 pKi = 8.2 Binding
NoneNone
Drug Central 1304 30 18 17 -4.4 N[C@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N1C[C@H](O)C[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=CS1)C(=O)N[C@@H](CO)C(=O)N1CC2=C(C[C@@H]1C(=O)N1[C@H]3CCCC[C@H]3C[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C=CC=C2 None
3812 717 42 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
439201 717 42 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
649 717 42 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL406291 717 42 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
DB12126 717 42 None -309029 6 Human 4.0 pKi = 4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
123643 3835 0 None -1 2 Rat 5.1 pKi = 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
639 3835 0 None -1 2 Rat 5.1 pKi = 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3812 717 42 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
439201 717 42 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
649 717 42 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL406291 717 42 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
DB12126 717 42 None -19498 6 Rat 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
123643 3835 0 None 1 2 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
639 3835 0 None 1 2 Human 5.2 pKi = 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
164234 3478 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
164234 3478 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8996175
643 3478 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
643 3478 0 None -35 2 Human 5.7 pKi = 5.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8996175
5311111 2175 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8302267
5311111 2175 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
650 2175 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8302267
650 2175 0 None -44 3 Mouse 6.3 pKi = 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
5311111 2175 0 None -25 3 Rat 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
650 2175 0 None -25 3 Rat 6.6 pKi = 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3812 717 42 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
439201 717 42 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
649 717 42 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL406291 717 42 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
DB12126 717 42 None -616 6 Mouse 6.7 pKi = 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
122227 1378 31 None -6 3 Rat 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3825 1378 31 None -6 3 Rat 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
644 1378 31 None -6 3 Rat 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL264100 1378 31 None -6 3 Rat 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
122227 1378 31 None -6 3 Mouse 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
3825 1378 31 None -6 3 Mouse 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
644 1378 31 None -6 3 Mouse 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL264100 1378 31 None -6 3 Mouse 8.8 pKi = 8.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
662 3680 0 None - 1 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 14747609
9853583 3680 0 None - 1 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 14747609
CHEMBL2021721 3680 0 None - 1 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 14747609
642 2308 19 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
642 2308 19 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL384721 2308 19 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL384721 2308 19 None 12 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
661 3279 0 None 63 2 Human 9.2 pKi = 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
654 566 0 None 10 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
654 566 0 None 10 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
654 566 0 None 10 3 Human 9.6 pKi = 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
655 567 0 None - 1 Human 9.7 pKi = 9.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16368899
655 567 0 None - 1 Human 9.7 pKi = 9.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9650825
122227 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
122227 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
122227 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
122227 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
3825 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
3825 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
3825 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
3825 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
644 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
644 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
644 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
644 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL264100 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL264100 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8735629
CHEMBL264100 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL264100 1378 31 None 6 3 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
658 2872 0 None 3981 2 Human 10.2 pKi None 10.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
665 973 3 None 1023 2 Human 10.5 pKi None 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
9916412 973 3 None 1023 2 Human 10.5 pKi None 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
CHEMBL189123 973 3 None 1023 2 Human 10.5 pKi None 10.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
5128451 1380 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
5128451 1380 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
646 1380 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
646 1380 0 None -2818 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
100978427 1379 0 None -35 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
645 1379 0 None -35 2 Human 5.8 pKi None 5.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
155817380 1393 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
648 1393 0 None - 1 Human 5.9 pKi None 5.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
102061602 1392 0 None - 1 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
647 1392 0 None - 1 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
651 262 0 None - 1 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
667 1973 37 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
71364 1973 37 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL2028850 1973 37 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
DB06196 1973 37 None -5128 6 Rat 6.3 pKi None 6.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
123884 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
123884 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
123884 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
123884 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9203620
123884 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
641 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
641 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
641 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
641 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9203620
641 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL80472 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL80472 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8063797
CHEMBL80472 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
CHEMBL80472 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9203620
CHEMBL80472 2306 14 None -87 3 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
653 565 0 None -316 4 Mouse 6.6 pKi None 6.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
667 1973 37 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
667 1973 37 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
71364 1973 37 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
71364 1973 37 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
CHEMBL2028850 1973 37 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL2028850 1973 37 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
DB06196 1973 37 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
DB06196 1973 37 None -1819 6 Human 6.7 pKi None 6.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
101607591 2432 0 None - 1 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
637 2432 0 None - 1 Human 6.8 pKi None 6.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
3081308 2871 0 None -15 2 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
657 2871 0 None -15 2 Human 6.9 pKi None 6.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8995263
44316620 2121 0 None -19 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10882364
656 2121 0 None -19 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10882364
CHEMBL408846 2121 0 None -19 2 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10882364
665 973 3 None -1023 2 Rat 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
9916412 973 3 None -1023 2 Rat 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
CHEMBL189123 973 3 None -1023 2 Rat 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 585 8 3 6 3.6 O=C(C[C@@H]1C(=O)Nc2c(N1S(=O)(=O)c1ccc(c(c1)Cl)Cl)cccc2)NCCc1ccc(cc1)C1=NCCN1 12812482
164234 3478 0 None 35 2 Rat 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
643 3478 0 None 35 2 Rat 7.3 pKi None 7.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
100978427 1379 0 None 35 2 Rat 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
645 1379 0 None 35 2 Rat 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
661 3279 0 None -63 2 Mouse 7.4 pKi None 7.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
663 1377 0 None -1 3 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
663 1377 0 None -1 3 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
663 1377 0 None -1 3 Rat 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
640 3627 0 None - 1 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
123884 2306 14 None -7 3 Rat 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
641 2306 14 None -7 3 Rat 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
CHEMBL80472 2306 14 None -7 3 Rat 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
663 1377 0 None 1 3 Mouse 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
653 565 0 None -15 4 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856115
653 565 0 None -15 4 Human 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
5311111 2175 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
5311111 2175 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
5311111 2175 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
650 2175 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
650 2175 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052
650 2175 0 None 25 3 Human 8.0 pKi None 8.0 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9313952
659 2898 17 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15341478
659 2898 17 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15685199
9831083 2898 17 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15341478
9831083 2898 17 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15685199
CHEMBL273869 2898 17 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15341478
CHEMBL273869 2898 17 None -1 2 Human 8.0 pKi None 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 659 9 1 7 3.6 CN1CCN(CC1)C(=O)C1CCN(CC1)S(=O)(=O)c1ccc(c(c1)C(=O)N1CCOCC1)NCC(c1ccccc1)c1ccccc1 15685199
642 2308 19 None -12 2 Mouse 8.1 pKi None 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL384721 2308 19 None -12 2 Mouse 8.1 pKi None 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
20814785 3203 0 None - 1 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 11 3 7 6.6 Clc1ccc(cc1)CNC(=O)C(Nc1nc(NCc2cccc(c2)Cl)nc(c1)n1ccnc1)CC1CCCCC1 10596850
660 3203 0 None - 1 Human 8.2 pKi None 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 577 11 3 7 6.6 Clc1ccc(cc1)CNC(=O)C(Nc1nc(NCc2cccc(c2)Cl)nc(c1)n1ccnc1)CC1CCCCC1 10596850
654 566 0 None -17 3 Mouse 8.3 pKi None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276157
123884 2306 14 None 7 3 Mouse 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
641 2306 14 None 7 3 Mouse 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
CHEMBL80472 2306 14 None 7 3 Mouse 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
654 566 0 None -10 3 Rat 8.6 pKi None 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10422787
10281725 979 0 None 7 2 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
666 979 0 None 7 2 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
CHEMBL299164 979 0 None 7 2 Rat 9.0 pKi None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
10281725 979 0 None -7 2 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
666 979 0 None -7 2 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
CHEMBL299164 979 0 None -7 2 Human 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 579 7 2 6 5.7 CCCN1C(=O)C(NC(=O)Nc2ccc(cc2)N2CCN(CC2)c2cccnc2)N=C(c2c1cccc2)C1CCCCC1 12723943
5128451 1380 0 None 2818 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
646 1380 0 None 2818 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8856107
652 562 0 None - 1 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16368899
636 3626 0 None - 1 Human 9.5 pKi None 9.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9111052